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Serologic and electrophoretic procedures were employed in the 
study of serum and urinary proteins from twenty-six patients with 
mUltiple myeloma. Hematological, radiological and other findings 
associated.withmyelomatous disease, or otherwise applicable to 
interpretative analyses of serological data, were reviewed. The 
serum and urinary proteins of these patients were found to have 
distinct electrophoretic properties and serQlogic characteristics. In 
this series, the M-components of four patients were classified 
serologically as Gamma-A paraproteins, two as Gamma-D paraproteins, 
fifteen as Gamma-G paraproteins and five were nonreactive with the 
available class specific antisera. Antigenic typing of twenty of 
these proteins with. light chain antisera gave a 1:1 ratio; that is, 
ten proteins reacted with lambda type light chain antisera and ten 
proteins reacted with kappa type antisera. 
Considerable diversification was present in the electrophoretic 
patterns of the serum and urinary proteins. The concentration of the 
electrophoretic fractions varied with the degree of proteinemia or 
proteinuria. Hyperproteinemia was evident in only fifty per cent of 
the gammopath~es included in this study. The evidence of an abnormal 
component ranged from negligible to the appearance of three distinct 
peaks in an electrophoretic region where only one peak usually occurs. 
Quantitative estimation of an M-component in the sera. ranged from 
negligible to 8.8 gm/100 mI. Proteinuria was demonstrated in the 
urine of eighteen of the twenty-three patients tested. 
The immunoglobulins were quantitated by a radial immunodiffusion 
technique. A correlation was apparent with the light chain antigenic 
type and alterations of the Gamma-G immunoglobulin level in the 
Gamma-A and Gamma-D myelomas. Myeloma proteins consisting of lambda 
type light chains were associated with reduced Gamma-G serum levels, 
whereas myeloma proteins consisting of kappa type light chains were 
associated with quantitatively normal serum Gamma-G levels. 
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SEROLOGIC CLASSIFICATION OF SELECTED CASES OF MYELOMA 
INTRODUCTION 
Derangements in gamma globulin synthesis are known to occur in 
conjunction with myelomatous processes. These changes may be observed 
as a narrow, dense protein zone in the electropherogram, or as a 
flocculent precipitate in thermal solubility testing for Bence Jones 
proteins. However, if the presence of a monoclonal peak in zone 
electrophoresis and the thermal properties of the Bence Jones proteins 
were the sole criteria for distinguishing the paraproteins, a goodly 
share ot the immunoglobulin aberrations would remain undetected. The 
development of immunochemical procedur~s has provided methods for the 
critical description of the immunoglobulins in the pathologic state. 
The paraproteins produced in the plasma cell dyscrasias appear 
to be derivatives of one or more of the immunoglobulins found in normal 
sera and are distinguishable from the polypeptides of these globulins. 
The presence of each isolated antibody within the immunoglobulin 
classes of normal sera reflects an immune response of the body. This 
response is partially characterized by the production of a distinct 
antibody with well defined physicochemical properties. In a like 
manner, the protein dyscrasias are characterized by the elaboration of 
large quantities of a homogeneous protein with well defined physico-
chemical properties. The uniqueness of these properties may account, 
to a large extent, for the individual clinical and pathologic 
manifestations, as well as the characteristic therapeutic response 
seen in individual cases of multiple myeloma. Because ,there are many 
diversified ways in which a dysproteinemia may be expressed, clinical 
management becomes difficult unless classification of the abnormal 
protein into one of the constituent groups of immunoglobulins with 
related properties can be made. 
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A definitive classification of the gammopathies depends upon 
phy\cochemic~l and serologic characterization of the serum proteins, 
an examination of the bone marrow, radiologic bone surveys and 
clinical evidence of the disease. The low incidence of the gammo-
pathies in the population makes it difficult to obtain a significant 
number of cases for evaluation. Nonetheless, continual studies must 
be conducted and evaluated on the limited number of cases encountered 
if a working knowledge of the myelomatous processes is to be obtained. 
Therefore, appropriate physicochemical and immunochemical procedures 
have been performed on specimens from selected myeloma patients. The 
results of these studies, together with additional findings, are 
presented herein. 
REVIEW OF LITERATURE 
I. HISTORICAL DEVELOPMENT OF THE IMMUNOGLOBULINS 
For many years antibody formation rem~ined an obscure phenomenon 
related in some manner to the properties of the serum. The 
contributions of investigators toward the elucidation of the 
biophysical and bioch~mical properties of antibody molecules has 
spanned over a century, and still many of the facets of this problem 
remain unresolved. However, today, antibody formation has been 
established as a function of globulin synthesis (Janeway and Gitlin, 
1957; Dreyer and Bennett, 1965). 
The characteristic solubility properties of the plasma globulins 
was first noted by the French Physician Pro~per-Sylvain Denis prior 
to 1859. (Denis, 1859). This observation led to the demonstration of 
differences in solubility of protein molecules when exposed to aqueous 
solutions of neutral salts, i.e. ammonium sulfate (Pohl, 1886), 
sodium sulfate (Howe, 1921a, 1921b), sodium sulfite, magnesium sulfate 
(Hammarsten, 1897), potassium citrate (Jameson, 1937), and mixtures of 
phosphates (Butler and Montgomery, 1933). These reactions are 
dependent upon many factors, namely, the concentration of the salt, 
the pH and the temperature. The exact chemical interaction involved 
in producing this effect is still incompletely understood. It is 
thought that the ionic groups on the surface of the protein molecules 
compete with salts for the molecules of solvent. This competition 
produces a shift in the equilibrium causing the proteins to be 
precipitated as a result of the salt ions being bound to the available 
aqueous phase (Cohn and Edsall, 1943; Haurowitz, 1935, 1936a, 1936b). 
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These salting-out procedures demonstrated that more than one separate 
protein entity, i.e. albumin and globulin, did in fact reside within 
the serum. During this same period, it was recognized that the 
globulin class could be further subdivided on the basis of solubility 
characteristics in salt-free water. The soluble globulin fraction was 
referred to as pseudoglobulin, while the precipitable portion was 
called euglobulin (Burckhardt, 1883; ,Marcus, 1899; Porges and SpU;;.o, 
1902; Hardy, 1905). 
It was not until the classical moving boundary electrophoretic 
studies of Tiselius (1930) that the distinct heterogeneity of the 
serum proteins was firmly established. This study prompted an 
improved electrophoretic system which characterized the serum globulin 
fraction as being a mixture of at least three components. Separation 
occurred as a function of the unique isoelectric pOints of each of 
these components when subjected to an electrical field at a known pH. 
The characteristic globulin fractions obtained were designated alpha, 
beta and gamma in order of decreasing mobility (Tiselius, 1937b). Of 
particular interest was the finding that pseudoglobulin was not 
confined to the albumin fraction, but contained alpha globulin and a 
small percentage of gamma globulin, while euglobulin consisted largely 
of beta and gamma with less alpha (Tiselius, 1937a, 1937b). At this 
early date, the marked possibility of further heterogeneity within 
each of the electrophoretically separable fractions was recognized. 
Immediately succeeding the identification of the alpha, beta and 
gamma globulin serum components; Tiselius noted the correlation of 
5 
antibody activity in purified preparations with the gamma globulin 
migratory fraction (Tiselius, 1937c). Currently, however, there is 
considerable evidence to indicate that it is erroneous to restrict the 
classification of antibodies to this electrophoretic fraction. 
Antibodies with different specificities, or even antibodies which 
cross-react may have electrophoretic mobilities ranging from the alpha 
through the gamma region (Williams and Grabar, 1955). Indeed, further 
studies in the 1940's with antibody-rich protein fractions led to the 
discovery of an antibody component with an electrophoretic mobility 
intermediate to gamma globulin and beta globulin, which was accordingly 
designated T, beta2 or gammal by various investigators (van der Scheer, 
et al., 1940; Kekwick and Record, 1941; Deutsch and Nichol, 1948). 
A description of beta2A globulin did not ensue until the 
introduction of the immunoelectrophoretic technique of Grabar and 
Williams (1955). This technique utilized the electrophoretic 
mobilities of proteins in agar gel in combination with the immunologic 
specificities obtained from the gel diffusion technique of Oudin 
(1946). The resultant precipitin arcs have enabled the detection and 
semi-quantitation of more than 30 separate serum components (Crowle, 
1961). 
Heremans (1960) introduced the term "immunoglobulins" to include 
the gamma2' gammalM and beta2A proteins. To date, there are three 
major (IgG, IgA, IgM) and two minor (lgD, IgE) distinct structural 
classes of immunoglobulins that have been reported (Rowe and Fahey, 
196~; lshizaka et &., 1966). The designation "immunoglobulin" is 
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used broadly to distinguish the production of antibodies by an immune 
mechanism from the globul,in produced "normally", or ,at least from aJ\ 
unknown antigen source. This latter non-specific a~tibody has been 
ascribed to a low combining stl.'ength'of antibody with the antigen 
(Haurowitz, 1942), an anamnestic response to a ,previously exposed 
antigen (Boyd and Be;rnard, 1937), or to a nonantibodyfunctionof a 
certain portion of the "natural" gamma globulin (Larson and Tomlinson, 
1952; Lawson.!:! al., 1955). As the 'sensitivity of the ,methods for 
detecting antibody reactions with the corresponding antigen increase, 
these "inert" gamma globulins may be identified as antibodies. The 
definition of the immunoglobulins has also been extended to include,' 
the myeloma proteins, Bence Jones proteins, and certain normal 
urinary protein components (Fahey, 1965). It appears that these 
latter proteins do,not function as antibodies (Gutman, 1948; Fahey, 
1965), but are sufficiently related structurally to merit inclusion 
in the immunoglobulin classification. IIi the instance of the myeloma 
protein, Kunkel and Slater (Kunkel and Slater, 1952; Slat,er.!!- ala , 
1955) demonstrated a precipitin reaction against t'he antisera of normal 
human gamma globulin. Bence Jones proteins .(~nnik and Kunkel, 1962; 
Fahey and Solomon, 1963; Nachman, et !l., 1965) and,normal urinary 
proteins (Webb, ~ al., 1958; Franklin, 1959; Remington, ~ al~, 1962; 
Stevenson, 1960; Berggard, 1961) which exhibit a serologic and 
structural relation to the immunoglobulins have also been described. 
Due to the multiplicity of investigators and the different animal 
species used in'the study of the structure and function of antibodies, 
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a formidable terminology has emerged to describe the antibody 
molecules. The nomenclature recommended by the World Health 
Organization (1964) and some of the properties which characterize the 
immunoglobulins are given in Table 1. 
Table 2 gives the products obtained from enzymatic and reductive 
cleavage of the antibody molecule by various investigators with the 
accepted W.H.O. nomenclature, the synonomous terminology used by the 
investigator, and the species used to obtain the product. 
II ENZYMATIC AND REDUCTIVE CLEAVAGE 
In the past, the antibody molecule was thought to consist of a 
single polypeptide chain (Porter, 1950). When the presence of more 
than one N-terminal amino acid in myeloma proteins was observed a 
multichain structure was suspected (Putnam, 1955). Because of the 
relative homogeneity and the copious production in disease states, 
the myeloma and Bence Jones proteins have served as model globulins 
to help determine the conformation of the antibody molecule. However, 
a rigorous classification of the subunit structure was not appreciated 
until enzymatic and reductive cleavage were applied to the antibody 
molecule (see Table 2). 
Enzymatic proteolysis has been used. extensively in characterizing 
native proteins. In order to derive an understanding of the 
mechanisms of enzyme hyd~olysis, Tiselius and Eriksson-Quensel (1939) 
subjected ovalbumin to pepsin and st~died the enzymatic degradation 
process in detail. Proteolysis was fi~st applied to the gamma 
TABLE 1 
HUMAN SERUM IMMUNOGLOBULINS 
IMMUNOGLOBULIN MOLECULAR SEDIMENTATION ELECTROPhORETIC NORMAL SERUM LEVEL 
W.H.O. NOTATION SYNONYMS WEIGHT COEFFICIENT MIGRATION (mg/m1) 
yG or IgG tY., 7Sy 
6.6S, Y2 150,000 6.6S gamma 12.4 <.±2.2) 
Yss 
yA or IgA B2A, ylA 150,000 6.68 slow b~ta 3.'9 ·(±O.9) 
. .(9,11,).3S) 
yM or IgM 
. YgM, B2M 
1 S, - 900,000 18S between gauma 1.2 <±O.35) 
macrog1ob- (24S, 32S) and beta 
u1in 
yD or IgD Y1 
J 160,000 7.04S between gamma 0.03(0. -0. 4) 
and b.eta 
yE or IgE None 8S between gamma unknown 
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Rabbit serum Porter (1959) 
Cohn Fraction II Franklin (1960) 
Human Y-globulin 
Human Y-globulin Edelman ~ al.,(1960) 
Rabbit serum Porter (1959) 
Cohn Fraction II Franklin (1960) 
Human Y-globulin 
Human Y-globulin Edelman ~ al., (1960) 
Rabbit antibody Nisonoff ~ al .• ,(196l) 
Fab-fragment Frangione & Franklin 
(1965a) 




Edelman & Benacerraf 
(1962) 
Rabbit antibody Porter (1962) 
7S Y-globulin Edelman & Benacerraf 
Myeloma.".glQbulin (1962) 
Bence Jones protein 
\0 
globulin molecule when Pope (1939) examined the effect of a pepsin 
digest on horse diphtheria antitoxin, but the major contribution 
eliciting an understanding of the structure of the antibody molecule 
can be attributed to the work of Porter (1959) with papain. The 
thoroughness of this work, coupled with that of Fleisc.hman (1963), 
set a pattern for the investigation of the immunoglobulins. 
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Porter (1959) observed that when pooled rabbit gamma globulin 
was partially hydrolyzed by crystalline papain, the antibody-combining 
site was retained in two of the three resulting fragments. These 
fractions were designated I, II and III in order of elution from a 
carboxymethyl cellulose column. Ultracentrifuge studies of these 
three components revealed a single peak at 82Ow, 3.5, suggesting 
that the 6.68 gamma globulin molecule has been split into three 
fragments of similar size. Palmer ~ al., (1962) have subsequently 
reported that the differences obtained in fractions I and II probably 
reflect the heterogeneity of the antibody population within a pooled 
preparation, rather than reflecting a difference in the subunits 
within the same. molecule. 
A number of workers adapted the experimental approach of Porter's 
work to an investigation of the cleavage of human gamma globulin 
(Edelman ~ al., 1960; Franklin, 1960; 8tiehm ~~., 1960; Hsiao 
and Putnam, 1961). Three major components were also obtained when 
Cohn fraction II of human gamma globulin was dissociated with papain 
and cysteine (Franklin, 1960). ~wo of these subunits, A and C, 
contained a univalent antibody site, while the third piece, B, had no 
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antibody site, differed in physical properties and could be 
crystallized. A further clarification of the role of enzymatic 
degradation was made possible by utilizing immunoelectrophoresis in 
conjunction with papain hydrolysis of the human gamma globulin 
molecule(Edelman.!! all' ,1960). In this instance, the two components 
that were obtained from the digest were compared electrophoretically 
and immunoelectrophoretically with the untreated purified gamma 
globulin molecule. One of these fractions migrated faster (F) than 
the undigested molecule and the other was electrophoretically slower 
(5). Immunoelectrophoretically, two precipitin arcs were demonstrated 
with the original 78 molecule. The 5 fraction, which was present in 
about twice the concentration of the F fraction, was antigenically 
related to the inner arc, while the F fraction was identified with the 
outer arc. 
Papain cleavage of the antibody molecule is effected by the 
hydrolysis of peptide .bonds formed py the carboxyl groups of alpha-
amino substituted arginine and lysine, and to a lesser extent 
derivatives of glutamine, histidine, glutamic acid, leucine, glyCine, 
and tyrosine. The magnitude of this hydrolysis is dependent upon the 
availability of reactive groups according to the conformational 
structure of the molecule (Hill, 1965), and upon the concentration of 
the protein, reducing agents, papain, and urea used in the degradation 
process (Gyenes ~ al",1966). It has been demonstrated electro-
phoretically that spontaneous degradation of stored human gamma 
globulin produces products similar to those obtained by enzymatic 
digestion with papain, trypsin or plasmin (Skvaril, 1960; Augustin 
and Hayward, 1960). 
A second approach to the degradation of the antibody molecule, 
reductive cleavage, has been more productive in yielding information 
for structural analysis. Reductive cleavage employs the disruption 
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of disulfide bonds by a variety of qgents such asmercaptoethanol, or 
other thiols, followed by stabilization of the reoxidizable sulfhydryl 
groups by alkylating agents, urea or acids. A subsequent "clean" 
separation of the fragments is obtained with ion exchange resins, 
differential dialysis, gel filtration or electrophoresis , (Fraenkel-
Conrat, 1963). 
In 1959, Edelman showed that the human 75 molecule, when exposed 
to mercaptoethanol in 6 M.urea, was disaggregated from a molecular 
weight of about 150,000 to a molecular weight of 50,000-60,000. This 
decrease indicated that the antibody molecule was probably composed 
of more than one peptide chain held together by interchain disulfide 
bonds. The products obtained by this reduction were biologically 
inactive and were insoluble in most aqueous solutions (Edelman and 
Paulik, 1961). Further studies with globulins of other species 
(Edelman and Poulik, 1961; Franek, 1961; Ramel ~~., 1961) confirmed 
these original findings, thus demonstrating.a similarity in general 
structure, i.e. more than one peptide chain per molecule. Previous 
studies relating to the multiplicity of the antibody peptide structure 
relied heavily on N-terminal group determinations. However, these 
amino acid analyses of gamma globulins from different species do not 
co):'relate with the above results (Pot:ter, 1960), which would suggest 
that some of these end groups are substituted or rendered inactive 
(Edelman and Poulik, 1961). 
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Since the retention of biologic activity in the degraded molecule 
is essential in determining the relationship of antibody function to 
antibody structure, a less drastic procedure that would not result in 
denaturation was sought. Under conditions of mild reduction, with 
mercaptoethanol in a neutral aqueous solution followed by fractiona-
tion in acid solution, tpis criterion was satisfied (Porter, 1962; 
Fleischman, ~A!" 1962). With this method the gamma globulin 
molecule was split into two types of polypeptide chains. The major 
component was designated A chain and the second fraction, B chain. 
The results of this study led to the postulation of a 4-chain antibody 
structu):,e (see Figure 1) (Po;ter, 1962). An analysis of amino acid 
composition, molecular weight determinations and of the products 
obtained under mild and full reduction was consistent with this 
hypothesis (Fleischman, et al., 1963). 
A second linear representation of the antibody molecule was later 
proposed by Tanford (Noelken ~A!., 1965) to account for the products 
obtained upon exposure to proteolytiC enzymes and reducing agents (see 
Figure 2). The experimental work with proteolysis and reductive 
cleavage methods have shown that the ant~body ~oleeule is composed of 
at least two types of polypeptide chains. These polypep.tides have 
been designated "heavy" (H-chain) and "light" (L-chain) on the basis 
of molecular weight determination (see Table 2 and Figure 3). Heavy 
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Figure 2. Schematic Representation ofa Y~Globulin Molecule as 
P~opo$ed by Tanford. 
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The folded portions of the polypeptide chains represent globular 
oriented portions of Y-globulin. The random coil in the central 
portion of theY-globulin molecule carries the disulfide bond. It 
represents the portion of thelllolecule m.ost sU$ceptible to enzymatic 
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Figure 3. Schematic diagram illustrating enzymatic digestion and 
partial redu~tion of the 7S antibody molecule. Numbers in parentheses 
are approximate molecular weights. (Adapted from Edelman and GaIly, 
1964) 
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chai~ bonding in the antibody molecule is now thought to be effected 
by a single disulfide bond rather than py the three inter-H-chain 
disulfide bonds originally proposed by Porter (see Figure 1). This 
second model allows for the independent rotation of each of the Fab-
fragments and the Fc-fragment around this inter-H-chain bond (see 
Figure 2). That such rotation does occur is supported by measurements 
of the depolarization of fluorescence energy (Noelken ~ al., 1965). 
A comparative analysis of the reductive products obtained in the 
presence and absence of denaturing agents was obtained by starch gel 
electrophoretic characterization in 9 ~ urea (Porter, 1962; Cohen, 1963a, 
196~~ Migration patterns revealed that the H-chain was equivalent 
to the A fraction, and that the B component could be equated with the 
L-chain. It has been reported that loss of immunologic activity of 
the antibody molecule with extensive reduction is due to the cleavage 
of 12 to 18 out of the 20 disulfide bonds, while cleavage of a maximum 
of 5 disulfide bonds with gentle reduction retains this activity 
(Porter, 1962; Fleischman, ~ al., 1962). 
The correlation of Fab and Fc (see Table 2) fragments with the 
heavy and light polypeptide chai~s was demonstrated by a number of 
investigators through immunologic specificities (Fleischman et al., 
1962; Olins and Edelman, 1962; Cohen, 1963a, 1963b; Nussenzweig, ~ 
al., 1964), molecular weight determinations (Marler ~ al., 1964), 
and radioisotope labelling (Olins and Edelman, 1964). From these 
analyses, it would appear that papain digestion produces a crystal-
lizable Fc fragment devoid of antibody activity which comprises a 
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portion of the H-chain, and two Fab-fragments each consisting of the 
remainipg portion of heavy chain and the entire L-chain. Each of the 
Fab-fragments contain a single antigen binding site. Subjection of 
the Fab-fragment to reduction and aklylation causes the heavy chain 
portion to dissociate from the L-chain (Fleischman, ~ al., 1963; 
Fougereau and Edelman, 1965; Heimer, 1966). This N-terminal H-chain 
piece is separable from the ligh~ chain by gel filtration and has been 
designated "Fd fragment" (see Figure 3). 
A topographical model of the 7.S antibody molecule, which takes 
into account all the known products obtained by degradation with 
proteolytic enzymes and by reduction of the interchain disulfide 
bonds, is presented in Figure 3 (Edelman and GaIly, 1964). Edelman 
and GaIly viewed the antibody ~olecule as a cylinder of elliptical 
cross section with dimensions of 2400A in length by~J:90A in width, 
consisting of a symmetric arrangement of two light polypeptide chains 
with molecular weights of 20,000-24,000 and two heavy chains with a 
molecular weight of 55,000-60,000. Polypeptide pairing is 
accomplished by the presence of three interchain disulfide bonds. 
Recently it has been suggested, on the basis of data obtained 
by electron microscopy, that the correct configuration of the gamma 
immunoglobulin may be trianguloid, 800A wide at the base, 350A high 
and 105 to l200A in length (Feinstein and Rowe, 1965). 
III ANTIBODY SPECIFICITY AND THE STRUCTURAL RELATIONSHIP 
The molecular localization of an antigen combining site on each 
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of the two identical Fab antibody fragments supports the concept that 
the 7S antibody molecule is bivalent (Porter, 1959; Kun~el, ~ al., 
1963). Further evidence of this valency is obtained under conditions 
of maximum antigen-antibody complexing in the presence of excess 
antigen, by the utilization of ultracentrifugal, electrophoretic and 
radioisotopic analyses, and equilibrium dialysis studies (Porter, 
1960). The identification of two cOJllbining sites of c t:he .s.ame antih9dy 
molecule has led to an investigation of the possibility of diverse 
biologic specificities at each of these two sites. It has been found 
that heteroligating antibodies can be produced by the formation of an 
artificial antibody from two monovalent fragments with different 
specificities (Nisonoff and~,Rivers, 1961). However, all analyses of 
the 7S molecule produced physiologically reveal that the two combining 
sites have the same specificity (Singer, 1965). 
Attempts to assign the binding site solely to either the L-chain 
or the Fd-fragment have been inconclusive. Recombination studies with 
separated specific and non-specific heavy and light chain polypeptides 
have failed to determine if the specificity of antigen binding 
activity resides exclusively in one of the polypeptide units. 
Specificity may reside either with the H-chain or with the L-chain, 
and in certain instances both chains are implicated (Grey, ~.!!.., 
1965; Lamm~ al., 1966). The observable variability in antibody 
behavior appears to be dependent upon the particular antibody involved, 
i.e. any given antibody seems to be characterized by a consistent 
localization of the antigen combining site. 
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A definition of the size of the antigen combining site rests upon 
inference from non-specific evidence. It has been observed, in 
certain instances, that an antigenic stimulus may produce a population 
of antibody molecules with site dimensions of variable size. This is 
manifest in studies with the antidextran and anti-DNP (dinitrophenyl) 
antibodies (Kabat, 1957; Singer and Doolittle, 1966). On the basis 
of information determined from free energies of antibody-hapten 
reactions by Schlossman and Kabat (1962), Merler and Rosen (1966) have 
estimated the area of the co~pining site to be no more than 5% of the 
entire molecule. In terms of amino acid composition, the region of 
antibody-antigen interaction has been estimated to consist of no more 
than ten to twenty amino acid residues'(Karusch, 1962). 
It has been proposed that the diverse biologic specificity found 
within the population of antibody molecules might be attributable to 
variable stereochemical orientation of the molecule at the active site, 
as a direct or indirect result of interchain and intrachain non-
covalent or disulfide bonding. The structural features of the antibody 
molecule that could contribute to the three-dimensional configuration 
are 1) the sequence of ,amino acid residues within each polypeptide 
c~ain, 2) the bonding of the polypeptide backbone, and 3) the 
conformation produced from the interaction of the four polypeptide 
chains. Each of these suggestions has b~en examined either separately 
or integrally to determine their contributing role in determining 
antigeniC specificity. 
Early work with antibodies led to the hypothesis that amino acid 
composition and sequence were identical for antibodies of different 
specificities, but that complementary antigen-antibody binding could 
be produced by a localization of different portions of the chain at 
the active site. This suggestion could be explained if there was a 
multiplicity of ways in which the chain could be folded. Specific 
folding was thought to be ~ediated by the formation of variable 
secondary and tertiary structures resulting from noncova1ent or 
disulfide bond stabilization rather than to fluctuation in the amino 
acid sequence (Karusch, 1957). More recently, studies with tryptic 
peptides and reoxidized polypeptide chains (Fleischman 1966) place 
some doubt upon certain aspects of this hypothesis. 
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In order to examine the role of primary structure in regulating. 
the specific folding of antibody chains, noncovalent and disulfide 
bonds have been cleaved and specific activity.reeva1uated after the 
molecule was refolded (see Figure 4, Watson, 1965). Specific activity 
was recovered with the disruption in quanidine of only noncova1ent 
bonds (Buckley, et a1., 1963; Noe1ken and Tanford, 1964). In as 
much as the formation of an active configuration could still be 
directed by disulfide bonds, methods for disruption of both non-
covalent and disulfide bonds were also employed (Haber, 1964; Whitney 
and Tanford, 1965). After exposure of the native protein to reducing 
conditions, the chains were found, by optical rotation, to be 
completely unfolded. The binding of the reoxidized and refolded 
soluble portion of the specific protein was compared to a control of 





Inactive folded protein 
Active protein 
Unfolding (denaturation) 
in 8 M urea and mercapto-






Refolding (renaturation) in 
air in absence of 8 M urea 
and mercaptoethanol 
Extended denatured protein 
Figure 4. Schematic illustration of the fate of S-S bonds during 
protein d~naturation and renaturation. When the denaturing agents 
are removed, most of the polypeptide chains resume the native 
configurations with the original S-S bonds. Only a few polypeptide 
chains old up in an inactive form characterized by a different set 
of S-Sbonds than those found in the native molecules. 
(Watson, 1965) 
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whereas 20 per cent of the specific material regained binding activity. 
These studies tend to demonstrate that the role of disulfide and 
noncovalent bonding as a determinant in the peculiar folding of the 
chains of the antibody molecule must be secondary to the amino acid 
sequence. If this is the case, then the extensive heterogeneity of 
the immunoglobulins must be sought through an explanation due to 
amino acid differences. 
There is no detectable significant difference in assays for 
relative amino acid content within each subgroup of the immuno-
globulins (Gitlin and Merler, 1961; Koshland and Englberger, 1963), 
but there is a unique primary sequence of amino acid residues 
associated with both the Hand L polypeptide chains. Contiguous to 
the variant region of the protein is an invariant amino acid sequence 
CODUDon to the particular chains. Peptide analyses indicate that the 
distinctive amino acid portion appears at the N-terminal end of the 
light chain, while the amino acid sequence on the C-terminal end of 
this polypeptiqe remains constant. Marked similarities of the heavy 
chains are seen on peptide maps of the Fc-fragment. The slight 
differences observed in a few of these H-chain peptides do not appear 
to reflect diverse antigenic specificities, but represent the 
variations characteristic of the genetic subgroups, We, Ne, Vi and 
Ge (Kunkel, ~ al., 1966; Merler and Rosen, 1966; Milstein, 1964; 
Titani and Putnam, 1965; Hilschmann and Craig, 1965). Due to 
impediments in preparing the Fd-fragment, sequence differences on 
this half of the H polypeptide are derived by inference from studies 
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of the entire heavy chain and the Fc-fragment (Frangione and Franklin, 
1965a and 1965b). These studies would indicate that considerable 
heterogenei~y in amino acid sequence also exists within this, the 
amino end, portion of the molecule. 
In addition to the role assigned to the primary structure of 
antibody in determining biological specificity, another structural 
feature has been indicated that imparts molecular specificity. Since 
the immunoglobulins consist of more than one peptide chain, the 
interaction of tertiary and quanternary structures due to cross 
linkages of the disulfide bond must be accounted for~A1though there 
is no confirmatory evidence that would ascribe specificity of the 
antibody site to tertiary structure due to random disulfide bonding, 
cross-reactions with the human immunoglobulins G and M due to tertiary 
and quanternary structure have been reported (Se1igmann, ~ al., 
1966). The possibility of this precipitin reaction being due to the 
common structural amino acid sequence present at the carboxy-terminal 
portion of the H-chain is made unlikely by the confinement of 
reactivity to the Fab-fragment. Cross-reactivity due to identical 
primary structure of the L-chains is ruled out by the use of two 
distinct antigeniC determinants, type K and type L (see Section IV). 
Common antigenic determinants. can be demonstrated in the IgM and IgG 
globulins. Conformational structure may account for this common 
denominator. Evidence for this likelihood is the necessity of heavy 
and light chain interaction before cross-reactivity can be observed. 
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IV IMMUNOGLOBULIN SUBUNIT CLASSIFICATION 
~:As,)previously stated, most antibody molecules consist of four 
polypeptide chains, two identical L-chains and two identical H-chains, 
symmetrically joined by three disulfide bonds into an elliptical 
configuration. The heavy chains impart the specific characteristics 
for each class, whereas the light chains account for the properties 
common to all classes (Franklin and Stanworth, 1961; Olins and 
Edelman, 1962). The immunoglobulins have been categorized into major 
and minor classes, subclasses and. genetic subgroups on the basis of 
antigenic diff erences ~ithin the polypeptide chains (Kunkel, &..!!.., 
1966; Fleischman, 1966). These differences are, in part, apparently 
a reflection of amino acid sequence differences (Singer and Doolittle, 
1966), which appear to be independent of the primary structural 
variations present at the antibody combining site. 
Because of the relatively low yield of immune globulins obtained 
from sera of normal individuals, for the most part, an identification 
of different antigenic determinants has depended upon the utilization 
of paraproteins from malignant disturbances. Each of the immuno-
globulin molecules have been found to exist in elevated serum 
concentration concurrently with plasma cell dyscrasias, that is, 
conditions where there is an infiltration of abnormal plasma or 
lymphoid cells in the bone marrow or tissues in association with 
derangements of gamma globulin synthesis. In the instance of the 
immune globulin D, it is only because of proliferative changes that 
the identification and description of the globulin itself has ensued 
(Rowe and Fahey, 196~} However, protein descriptions based on 
reactions of identity or nonidentity with antis~ra from protein 
dyscrasias introduce certain advantages as well as certain inherent 
errors in classification. 
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First, globulins used as antigens from the plasmacytoid and 
lymphocytoid dyscrasias elicit the production of highly specific 
antibodies, characterized by sharp electrophoretic banding, precise 
mobility, and a discrete reaction of identity with the neoplastic 
antigen. However, several groups of investigators have reported that 
in the majority of instances, specific individual antibody reactivity 
may be absorbed out by repeated exposure to pooled normal gamma 
globulin (Grey, ~ al., 1965; Seligmann, 1965). These findings may 
indicate that the presence of large quantities of distinct homogeneous 
protein components simply represents some unknown highly selective 
mechanism for the production of a finite portion of the normal 
antibody spectrum, or it may be that the abnormal globulin is so 
closely related to the antibodies within the normal spectrum that 
cross-reaction is possible. While cross reactions with antibody from 
malignant clones allow for specific identification, it also limits 
classification to those proteins which are readily accessible because 
of a defective control in protein synthesis. In all probability many 
more classes, subclasses and subgroups will remain unidentified until 
selected by protein disturbances or until other methods for detection 
are utilized. 
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A second conern in the classification of the immunoglobulins is 
the differentiation of the H-chain subclasses from the major and minor 
immunoglobulin classeso In both cases, the antigenic determinants are 
present on the heavy chain polypeptide. If the cross reaction is 
confined to the Fc-portion of the heavy chain, then the protein is 
designated as a subclass. If no reaction occurs with the H-chain, a 
new immunoglobulin class is recognized. Recently, the validity of 
this approach has been questioned (Kunkel, etal., 1966), in that, 
partial cross reactivity of the different immunoglobulin H-chains has 
been reported (Kunkel, et.!!., 1965). 
Using specific rabbit and monkey antisera, at least four 
subclasses have been delineated in the Gamma-G class (Dray, 1960; 
Kunkel, ~ al., 19641;>; Terry and Fahey, 1964). These subclasses have 
been designated Ne (Y2a)' We (Y2b), Vi (Y2c)' and Ge (Y2d) (Kunkel, 
et al., 1964b: Martensson and Kunkel, 1965; Grey and Kunkel, 1964). 
Of the three antigenic determinants detectable by rabbit antisera 
(Fleischman, 1966), two have been found on the Fc-fragment (Terry 
and Fahey, 1964; Grey and Kunkel, 1964), while a third was detected 
on the F(ab')2 fragment (see Table 2). The specificity was lost 
with the reduction of the latter fragment, indicating that the 
disulfide bond may be involved (Grey and Kunkel, 1964). The other 
classes of human heavy chain immunoglobulin components are less well 
studied. 
Two different types of L-chains, kappa and lambda, are recognized 
serologically. Both of these antigenic types occur in the light 
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chains of all four of the immunoglobulin classes (Fahey, 1963). By 
utilizing the unique serologic reactivity of the M-proteins (see 
Section VI) antigenic subtypes within both the type I (type K or 
kappa) and type II (type L or lambda) polypeptides have been described 
(Epstein and Gross, 1964; Nachman, et al., 1965; Williams, 1964). It 
has been possible to delineate at least ten different antigenic 
determinants of the kappa type (Solomon, ~ al., 1965). 
In addition to the antigenic differences of the types and 
subtypes of the light polypeptide chain, it appears that there is a 
unique antigenic specificity of individual light chains. This distinct 
specificity has been demonstrated through cross-reactions of Bence 
Jones antisera absorbed with pooled 7S gamma globulin (Mannik apd 
Kunkel, 196~~ The Bence Jones proteins have been found to correspond 
to the light chains of both normal and myeloma immunoglobulins 
(Edelman and GaIly, 1962; Putnam, 1962; Cohen, 1963b). 
Individual light chain differences are not only demonstrated by 
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the absence of cross reactivity wdth other kappa type proteins, but 
are, also, reflected in an analysis of the amino acid sequence of the 
variant portion of the polypeptide. The 212 amino acid residues 
(Hilschmann and Craig, 1965; Titani, et al., 1965; Milstein, 1966) of 
the kappa protein have been the most extensively studied. The C-
terminal sequence comprising res,idues 106 to 212 appears to be the 
same for different kappa proteins with the single exception of residue 
189. Variable regions of amino acid sequence occur on the N-terminal 
half of the ch~in. This portion of the chain contains residues 1 to 
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105. Considering all the type K Bence Jones p~oteins studied, 22 
positions of interchange, involving 32 substitutions and 26 different 
pairings of amino acids have been substantiated (Titani, et al., 1966). 
These areas of variability have been found to be restricted to 
segments of the molecule around the half-cystine residue at positions 
23 and 86 and the "switch peptide", constituting residues 102 and 105. 
Recently, investigators have correlated certain of the 
polypeptide amino acid sequence variants with genetic polymorphism. 
Both the heavy and the light chains have been. found to contain 
inheritable antigenic determinants reflected in structural hetero-
geneity. The genetic factor associated w;lththe H-chain of the 78 
immunoglobu~in is designated as the Gm group, whereas the,L-chains 
contain thelnv antigens (Kunkel, ~ al., 1964b; Lawler and Cohen, 
1965). 
The Gm factors represent a group of 14 serologically distinct 
groups, represented by the numbers 1 through 14 (W.H.a., 1965). 
The basis for the difference between a Gm (1) positive and a Gm, (1) 
negative serum has been. reported to be due to one amino acid 
(Baglioni, ~ al., 1966), while the serologic distinction of Gm (1) 
from Gm (4) and Gm (5) reflects a substitution of two amino acids. 
The Gm subunits appear to bear a direct relationship to the Ne, We, 
Vi and Ge H-chain subclasses (see Figure 5). 
Similarly, peptide mapping has been done with the two different 
types of light chains, using the Bence Jones proteins. Any monocolonal 
















)--~-- Gm (5) 
Schematic diagram of the chains of gamma globulin for the major We 
subgroup and the .. Vi subgroup with the approximate position of Gm and 
Inv factors on these chains (Kunkel, .!:! al., 1966). 
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polypeptide, either of type K or type L (Bernier and Cebra, 1964; 
Potter, ~ al., 1965). Thus, it is understandable that isolated 
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Bence Jones proteins ·might yield valuable information pertaining to 
amino acid sequence. In the ana1y~es reported (Putnam,aJl~ .~s4f1¥, 'J1965) 
there has been very little coincidence found in the tryptic peptide 
maps of the kappa and lambda proteins, although, an analysis of amino 
acid sequence has shown considerable homology in primary structure 
(Titani ~ a1., 1967). This group of investigators has recently 
demonstrated many areas of identity of amino acid pairs when the 
sequence of the two types of chains are aligned. Other regions of 
the polypeptide chains are noted that probably differ only by the 
substitution of an amino acid, possibly due to single nucleotide 
changes within the codon. 
Only one difference of current significance is seen in the 
terminal region at the carboxy-end of the kappa molecule. This 
difference involves the substitution of a single amino acid at 
position 189 and is directly related to the genetic determinant of 
the Inv group. The peptide substitution is a valine-leucine inter-
change. The presence of leucine is concurrent with the serologic, 
typing of the Inv factor (2), while serologically negative Inv (2) 
corresponds with the presence of valine in position 189 (Baglioni, 
~ al., 1966). 
V IMMUNOGLOBULIN BIOSYNTHESIS 
Basic to an understanding of the structure and function of 
antibodies is the development of a concept of their biosynthesis. 
For many years attempts have been made to learn the mechanism 
involved in the selective stimulation of large quantities of a 
complementary antibody to a particular antigen. These studies have 
been subject to considerable d~fficulties and inconsistencies. 
Consequently, to date, no irrefutable model has been proposed that 
would coordinate the relevant findings of the investigators in this 
field. A number of hypothesis of antibody formation are currently 
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a matter of conjecture (Singer and Doolittle, 1966). However, no 
attempt will be made here to review current concepts of the 
physiologic site or the biochemical process of antibody formation. 
Evidence concerning the cells involved in antibody production and the 
formation of H- and L-chains is related to the subject matter under 
consideration. 
Immunofluorescent localization studies (Burtin and Buffe, 1963; 
Solomon, ~ al., 1963q) and radiOisotopic techniques (Meyer, 1962) 
have demonstrated that the production of a gamma globulin component 
is a function of plasmacytoid and lymphoid systems. While there is 
ample evidence to establish the immunological competence of 
lymphocytes and plasmacytes, the immune mechanism is,. also, 
characterized by the conspicuous presence of other cellular types 
with undefined function. These cells are the primitive reticular 
cells, macrophages and eosinophils (Fitch and Wissler, 1965). 
Conflicting opinions exist relative to splenic involvement and 
antibody differentiation. The.fluorescent antibody studies of 
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Bernier and Cebra (1964 and 1965) with human lymphoid and splenic 
tissue indicate that within a given cell there isa concurrent 
production of H- and L-chains. This synthesis was found to be limited 
to one of the heavy chain subclasses (y, a, ~ or 6) and to one of the 
light chain subgroups (K or A). The site of this differentiation has 
been confined through the utilization of radioisotopic labelling to 
the splenic red pulp by other investigators (Pernis and Chiappino, 
1964). These data are in agreement with the earlier work of Fagraeus 
(1948) on splenic histology and the development of humoral antibody. 
The studies of Pernis and Chiappino did UQt show preferential 
synthesis in the germinal centers of the lymphoid follicles, in the 
white pulp of the spleen, or iu the lymph nodes. Contradictory to 
these studies is the work with immunofluorescent staining of Mellors 
and Korngold (1963) and Carbonara, ~ al., (1963). These 
investigators reported the demonstration of Gamma-A in the splenic 
white pulp, in plasma cells of lymph nodes, and in other lymphoid 
tissue. The coincidental staining for both IgG and IgM was, also, 
reported in individual cells of the germinal centers of lymph nodes. 
However, Pernis and Chiappino (1964) offer a feasible explanation for 
this apparent contradiction in the role of splenic white pulp and 
splenic red pulp. They suggest that the germinal centers of the 
lymphoid follicles in the white pulp of the spleen and in lymph nodes 
may not be committed to the synthesis of a particular type of gamma 
globulin, whereas the individual cells of the splenic red pulp produce 
only one type of immunoglobulin molecule. 
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Mannik and Kunkel (1965) interpret the staining of Gamma-A in the 
lymph nodes, coupled with the in vitro radioactive incorporation of B2A-
globulins in human lymph nodes (Asofsky and Thorbecke, 1961) as 
evidence for the synthesis of this immunoglobulin within the lymph 
node. Nonetheless, immunofluorescence and radioisotopic labelling as 
used in all of the'above studies are subject to interpretative analysis. 
First, allowance must be made for the presence of the immunoglobulins 
in interstitial fluid and for cellular interdigitation. Second, the 
validity of using these techniques as an index for synthesis must be 
taken into account. In these studies the demonstration of an immuno-
globulin within a cell is assumed to denote cellular biosynthesis. 
While single cells may engage in a simultaneous production of 
both heavy and light polypeptide components of the antibody molecule, 
there is evidence that quantitative differences in the formation of 
the two types of chains and their subgroups exist w,ithin a given cell 
and from cell to cell. Disproportionate heavy and ,light chain 
production becomes apparent within a single cell, i.e., the de!!2:Y:2. 
production of L-chains appears to exceed the occurrence of H-chains 
within the same cell (Shapiro, ~ al., 1966). It is thought (Mannik 
and Kunkel, 1965) that immunologically competent cells may have the 
potential of producing all immunoglobulin molecul,es, but once 
differentiation synthesis occurs all other types of immunoglobulin 
molecules are repressed. Since individual cells pre~erentially 
synthesize only one of the polypeptides from the heavy chain subclass 
and one from the light polypeptide subgroup, the relative frequency 
of these polypeptide types is determined by a cellular different.tal. 
Type I (kappa) cells are detected more frequently than type II 
(Lambda) cells (Bernier and Cebra, 1965). Of the heavy chain 
molecular classes, only IgA and IgG were quantitated. Gamma (IgG) 
containing cells appeared with a slightly greater frequency than 
cells containing the alpba(IgA) polypeptide. 
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Expected type frequenaes of immunoglobulin molecules within the 
cellular population may be predicted from the known serum concentrations. 
The quantitation of the light polypeptides roughly parallels the 
quantitation of the serum immunoglobulin levels of kappa and lambda 
chains; approximately 60% of cells stained for the kappa molecule and 
40% for the lambda. The differences observed in the frequency 'of the 
H-chain subclasses could not be accounted for on the basis of serum 
concentrations, in that the production of alpha chains was only 
slightly exceeded by cells containing gamma chains. Catabolic rates 
must, also, be given consideration, as well as the relation of the 
serum concentration to the total body pool (See Table 3). When the 
half life of these molecules is correlated with the synthetic rate, 
the differences in cellular occurence can be readily explained 
(Bernier and Cebra, 1965; Fahey and Robinson, 1963). 
The hypotheses proposed to describe the nature of antigenic 
sttmulation of antibody may be relegated into two broad groups, 
elective and inst:r:uctive (Lederberg, 1959), on the basis of the role 
assigned to the antigen. The elective hypotheses depend upon the 
idea that antigen preferentially stimulates specific complementary 
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IgG 28 mg/kg/ day 
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IgM 5-8 mg/kg/day 
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IgE Undetermined 
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antibody from hhe gamut of inhere~t globulins. The instructive 
hypotheses consider the:role of the antigen as either a direct or 
indirect template, acting at the antibody-synthesizing sites. 
Throughout the development of antibody synthesis concepts, one or the 
other of these hypotheses has gained favor, yet neither independently 
satisfactorily explains the antibody response. 
Currently, instructive hypotheses are in least repute. In spite 
of attempts to prove or disprove the template function of antigen, 
the problem remains unresolved. This problem has been approached 
through a study of antigen binding at the protein-synthesizing sites. 
Wellensiek and Coons (1964), _using ferritin as an antigenic stimulus, 
were unable to demonstrate a cellular localization of antigen in ,the 
primary response, but th~ secondary response was characterized, by the 
presence of ferritin within the plasma cells. In contrast to this 
work are the reports of Manner et al., (1965) and Nossal ~~., 
(1965). A study of the late stages of the 7S antibody response to 
r l25-labeled Salmonella flagella, showed no antigen in the antibody-
forming cell (Nossal et al., 1965). Manner's experiments were 
concerned with the binding of radioactive antigen to the presumed 
gamma-globulin-synthesizing ribosomal aggregates. Again, no 
significant binding was demonstrable. These experiments were unable 
to exclude the ins,tructive theory, due to the possibility that 
antibody induction may not be invoked by the intact antigen molecule 
serving as a hapten and combining with a protein component to effect 
antibody production. Garvey and Campbell (1957) have contributed to 
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the hapten hypothesis by demonstrating antigen degradation in the 
liver, followed by the complexing of these fragments with .soluble-
ribonucleic acid ~+RNA). Dissociation of the fragmentedantigen-S:~mlA 
complex resulted in the loss of fmmunogenicity of both the antigen 
fragment and thesTRNA. More recently evidence has accumulated which 
suggests that macrophages process ingested antigen and then transfer 
new information concerning gamma globulin synthesis· to the antibody 
forming cells in the form of messenger-ribonucleic acid (m-RNA) or 
as an RNA-antigen complex (Fishman, 1961jFishman and Adler, 1963; 
Mollo ~ al., 1963; Nossal ~ al., 1964; Askonas and Rhodes, 1965). 
Even though there is equivocation concerning the nature of antigenic 
induction, there is still objection to this hypothesis, i.e., the 
failure to explain anamnesis (Talmage and Cohen, 1965). 
Elective theories came into prom,1nence with Burnet' s (1957, 
1959) modification of Jerne's (1955) hypothesis of antibody 
production. This introduced a genetically determined cellular basis 
for the elective mechanism. This postulate readily accounts for the 
factor unexplained by template theories, that of cellular memory; 
nevertheless, natural selection is not without its difficulties. Of 
primary concern has been the plausibility of DN~ hypermutability 
taking precedence over accurate replication in the evolutionary 
origin of polypeptide antibody (Hill, ~ al., 1966; Singer and 
Doolittle, 1966; Titani, ~ al., 1967). The premises upon which 
natural selection are based have been examined, and the theory 
enlarged and altered in an effort to explain these inconsistencies.· 
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Amino acid analyses have demonstrated a sharp segregation of a 
constant and variable portion within each of the constituent poly-
peptide chains of the antibody molecule. Consequently, Franklin 
(F~ione and Franklin, 1965b) was prompted to propose an eight chain 
gamma globulin molecule to account for this synthesis. The proposal, 
that each of the polypeptide chains might, in fact, be two separate 
chains synthesized by different genes could ,be supported if a chemical 
bond linking these chains could be demonstrated. However, attempts 
to detect disulfide, ester or other nonpeptide bonds (Bennett, ~al., 
1965; Dreyer and Bennett,1965) give no indication that subchain 
synthesis is involved. Nonetheless, subchain or subunit synthesis 
remains an attractive hypothesis to explain the amino acid sequence 
variability on the NH2-terminal half of the heavy and light poly-
peptides. It has been further suggested that-aberrance may be 
produced by, the mode of combination of these units (Stenzel, ~ al., 
1964). The feasibility of subunit synthesis received impetus from 
the demonstration of short subunit gamma globulin synthesis on 
relatively smal! ribosomal aggregates and on single ribosomes (Manner 
~ al., 1965). However, in contradistinction to this report are the 
experimental results of Tawde, et a1., (1966). Originally, Scharff 
and Uhr (1965) reported nascent protein bound to single ribosomes and 
small aggregate,s, but further investigation showed that the poly-
ribosomes had been degraded by endogenous ribonuclease within the 
system. The l~tter report of these authors has indicated that gamma 
globulin synthesis takes ,place on polyribosomes and is dependent upon 
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the continued synthesis of RNA from a DNA template. 
In order to construct a theory that would obviate the improbability 
of hypermutabi1ity, certain facets of the molecular basis of antibody 
formation must be t:ecognized. A few, of these considerations are 
enumerated: 1) The consistency in replication of the amino acid 
sequence of the carboxy-terminal half of the heavy and light poly-
peptides would indicate that this portion of each of the chains was 
either the product of a single gene, or the product of two or more 
genes derived by gene duplication of a common ancestor. Whereas, the 
gross heterogeneity at the amino-end of these polypeptides could be 
produced from innumerable other genes. 2) The immunoglobulin anti-
genic determinants do not appear to be inherited as alleles. This is 
because, for the most part, each antigen is present in all individuals 
and is expressed in the serum at a constant level (Mannik and Kunkel, 
196~). 3) The antigenic determinants are probably characterized by 
separate genetic loci and are not subject to segregation, as evidenced 
by their presence in a consistent ratio. For example, kappa and 
lambda chains are found in a 3:2 ratio in plasma cells and in the 
serum. 4) It has been indicated that the structural cistrons for 
certain of the antibody heavy chain phenotypes are adjacent, or are 
in close proximity on the same chromosome (Herzenberg, 1964; 
Lieberman, ~ a1., 1965). 5) In relation to gene information transfer, 
any functional theory of antibody synthesis must provide a mechanism 
for the DNA or RNA code to be formulated from the antigenic stimulus 
and a mechanism for subsequent regulation. 
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Other hypotheses have been advanced that would replace or account 
for the apparent phenomenon of hypermutability. Smithies (1963) has 
proposed a mUltiple crossing over scheme between the strands of 
nucleic acids that code for the variable portions of the molecule. 
Another suggestion (Potter, ~ al., 1965) is that the different amino 
acid sequences present at the active site region could be regulated 
by unusual triplets locat.ed at key positions on particular portions 
of the molecule and could be read alternately by different acceptor 
RNA molecules with independent specificities. Dreyer and Bennett 
(1965) would explain peptide variances by an insertion of an aberrant 
section into the uniform region of the aming acid sequence by a 
mechanism analogous to the association of the A-virus with the 
Escherichia ~ chromosome. 
Perhaps of most significance in elucidating the enigma of seeming 
erratic polypeptide replication are the recent studies of Hill, ~ al., 
(1966), Singer and Doolittle (1966), and Titani ~ al., (1967). These 
authors reported a chemical homology be·tween the Fc- fragment of the 
heavy chain and the invariant half of the kappa light chain. A 
chemical relationship between the variant half of the light chain and 
the Fd-piece from the heavy chain was also suggested. Furthermore, 
these studies indicate hypermutation is probably not the functional 
mechanism involved in antibody heterogeneity, but that heterogeneity 
may have resulted from the accumulation of one step mutations in 
multiple genes which were originally derived by an evolutionary 
process involving gene duplication from a single primitive ,gene. 
VI THE MYELOMArOSES 
Classically, multiple myeloma is defined as a neoplastic 
proliferation of plasma cells with an elaboration of an M component 
in the serum and/or urine, and mUltiple skeletal lytic lesions, 
frequently in association with anemia, hypercalcemia, coagulation 
disorders and renal impairment (Osserman, 1965). The designation, 
M component, was introduced by Riva (1957) to denote structurally 
unique, homogeneous proteins in pathologic states that are increased 
in the serum or urine. Structurally, these abnormal proteins 
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resemble the "normal" immunoglobulins to such an extent that it is 
difficult to state with any certainty whether the M component 
represents a hyp~rplastic synthesis of a finite globulin from the 
gamut of inherent globulins, or consists of an aberrant synthesis of 
an abnormal protein (Edelman,.and Poulik, 1961; Edelman et al., 1961). 
In any event, it is evident that the capacity to produce functional 
antibodies is impaired (Lawson, ~~., 1955). Usually, the presence 
of an M component from one of the heavy chain subclasses is associated 
with a pronounced decrease of all other immunoglo,bulin classes 
(Osserman, and Lawlor, 1961). The mechanism for the synthesis of the 
inununoglobulins in the myelomatoses may be considered to be disrupted 
both from the standpoint of the production of a functional antibody, 
and in the maintenance of an equilibrium between the catabolic and 
anabolic rates of these globulins. The hypothesis may be formed that 
some process exists which preferentially favors synthesis in the 
neoplastic cell line and which depresses the activity of all other 
existing gamma globulin-synthesizing cells. 
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The myelomatoses have been classified according to the polypeptide 
compositions of the M component (see Table 4). Abortive $ynthesis of 
the antibody molecule may occur as an excessive cellular proliferation 
of the light polypeptide constituent, as a disproportionate increase 
in heavy chain production, or the neoplastic cell line may produce a 
whole myeloma protein containing both heavy and light chains. When 
the M component consists Of heavy chains in combination with light 
chains, the myeloma is classified in accordance with the antigenic 
typing of the heavy chain determinant. The most recently described 
myelomatosis of this classification is Gamma-D (Rowe and Fahey, 196!ij) .• 
Gamme-E protein has been described (Ishizaka, ~ al., 1966), but has 
not, as yet, been implicated in the myelomatoses. The term "light 
chain disease" has been used to describe the presence of free L-chains 
in the serum (Williams, ~ al., 1966). This disease was first 
recognized as a hypogammaglobulinemia with a continual absence of 
serum M components by paper or cellulose acetate strip electrophoresis. 
Elevated serum levels of free L-chains may be detected by immuno-
diffusion; however, this finding is not confined to hypogamma-
globulinemic states of myeloma. A t~ird state where aberrant 
proteins are produced is known as "heavy chain disease" (Franklin, et 
al., 1964). The first observed instance of an excess production of 
the IgG heavy polypeptide chain was reported in 1964. The presence 
of large quantities of the IgA and IgM heavy polypeptide determinants 
TABLE 4 
ABNORMAL IMMUNOGLOBULIN SYNTHESIS 
CLASSIFICATION MOLECULAR ,STRUCTURE 
1. Multiple Myeloma 
YA Type a X- Ci K 
YG Type ):2 X-2 y2 K2 
YD Type 02 X- 2 02 K2 
2 2 2 2 
X- or X- L-chains 
K or K2 L-.chains. 
2 
(As above without L-chains) 
Bence Jones Type (Normoproteinemic) 
X- or 'X- L-chains 
K or K2 L-chains 
2 
'!. Macroglobulinemia (YM) (ll X- )n; {J.i K)n 2 2 ,2 2 
3. H-Chain Disease Y - H-Chains 
4. L-Chain Disease X- or X-2 L-chains 




























in the serum or urine is yet to be described. A relative distribution 
of the immunologic types of gammopathies is presented in Table 5. 
As may be seen from Table 5, the presence of Bence Jones protein 
is frequently a characterizing parameter of the myelomatoses. 
Possibly, because of the small molecular size of the light chains, 
these proteins are cleared in the kidney and appear in the urine 
without apparent degradation. This allows for the categorizing of 
these proteins into one of the two serologically distinct light chain 
subgroups, kappa or lambda. As a general rul~ patients who exhibit 
kappa type myeloma proteins in the serum: also excrete the kappa 
Bence Jones protein. Likewise, lambda type Bence Jones proteins are 
usually associated with lambda myeloma proteins (Mannik and Kunkel, 
1962; Migita and -Putnam, 1963). 
TABLE 5 
APPROXIMATE DISTRIBUTION OF IMMUNOLOGIC TYPES 




1. Multiple Myeloma 
Hypergammaglobulinemic 
Gamma-A Type 20-25 
Gamma-GType 50-55 
Normoproteinemic (Bence Jones) 
Gamma-D Type 3 
L-Chain Disease 5-20 
Unclassified 2 
2. Macroglobulinemia 10-20 
3. H-Chain Disease (five reported cases) 
4, Unclassified 1.5 










MATERIALS AND METHODS 
I SERA 
Fresh and stored serum samples were studied from patients with 
the clinical diagnosis of multiple myeloma at the Latter Day Saints 
Hospital. Blood samples were collected and allowed to clot at 37oC. 
The samples were centrifuged and the serum was separated. The sera 
were preserved by adding either powdered met1hiolate (Thimerosal, NF, 
Eli Lilly & Co.) or sodium azide to give a final concentration of 
0.1% (w/v). The specimens were then refrigerated at 40 C or frozen at 
-20oC until serologic procedures were performed. 
II URINE 
Twenty-four-hour urine samples from patients with mUltiple 
myeloma were collected in refrigerated bottles containing m~iolate 
as a preservative. The urine specimens were clarified by 
centrifugation and a portion of the twenty-four-hour sample was 
concentrated 10 to 100 fold by dialysis against a 30% (w/v) polyvinyl-
pyrrolidone (PVP, General Aniline & Film Corp.) solution made isotonic 
with sodiumlchloride. In some instances, another portion of urine 
was mixed with a saturated solution of ammonium sulfate and the 
precipitate was dialyzed against distilled water and finally against 
30% PVP. 
III CELLULOSE ACETATE ELECTROPHORESIS 
Electrophoretic separation and quantitation of seru~ and urine 
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protein fractions were performed on cellulose acetate strips using a 
micro system (Beckman Instruments., Fullerton, California). 
A. Veronal Buffer 
A veronal buffer solution, pH 8.6, ionic st.rength 0.07S, was 
prepared according to the following formula: 2.76 g S,S-diethyl-
barbituric acid and lS.40 g sodium S,S-diethylbarbituric acid in 
distilled water to make 1 liter. 
B, Protein Stains 
Two dye solutions were prepared. One, a routine protein stain 
(Ponceau-S), was used as a primary stain on cellulose acetate 
membranes containing both urine and serum protein samples. The 
second dye (Nigrosin) was used as a counterstain because of its 
greater affinity for proteins and was required only in staining for 
low protein concentrations in the urine preparations. Ponceau-S dye 
fixative solution contained 0.2% (w/v) Ponceau-Sstain, 3.0% (w/v) 
trichloroacetic acid and 3.0% (wlv) sulfosalicylic acid in water. 
The Nigrosin stain was made to 0.002% (w/v) in aqueous acetic acid. 
C" Procedure 
Cellulose acetate membranes saturated with buffer were mounted 
on the Microzone ® electrophoretic cell bridge and serum samples 
(.0003 ml) or urine samples (.0003 to 0009 ml) were applied. Electro-
phoresis was performed at a constant current of S milliamperes (ma) 
for twenty minutes at room temperature. The membrane was removed 
from the bridge and immersed ina Ponceau-S fixative dye solution for 
10 minutes. The membrane was then transferred to a S% aqueous acetic 
acid rinse until the background was clear. The membranes containing 
the serum samples were placed in an absolute methanol rinse for 1.5 
minutes and transferred to a clearing solution of 20% glacial acetic 
acid in absolute methanol for 1.5 minutes. While still in solution, 
the membranes were positioned over glass plates. The membranes 
attached to the glass plates were dried at 1000C for ten minutes. 
The transparent membranes were then inserted into protective plastic 
envelopes, scanned and quantitated on the Analytrol ® equipped with 
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microzone attachment (Beckman Instruments, Fullerton, California). A 
B-a optical density cam, a 500 mu interference filter in the rear 
position, and a 520 mu filter in the front position were used on the 
Analytrol with the slit width selector completely open. 
The procedure in staining and quantitating the urinary proteins 
was the same as for the serum proteins, except for the following 
additional steps: After the last 5% aqueous acetic acid rinse the 
membranes were transferred to a Nigrosin stain and left in this 
solution overnight. The stained membranes were then again taken 
through the acetic acid rinses. 
IV IMMUNOELECTROPHORESIS 
A. Antisera 
All antisera used throughout these studies were procured from 
Hyland Laboratories, Los Angeles, California. The polyvalent anti-
sera were commercial preparations obt'ained from animals (horse, goat, 
and rabbit) hyperimmunized with pooled normal human sera. Commercial 
immunoglobulin class specific (IgG, IgA and IgM) -antisera and light 
chain (kappa and lambda) antisera were prepared by animal hyper-
immunization with an appropriate paraprotein. 
B. Verona1 Buffer 
1. Tank Buffer 
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The tank buffer solution was made according to the following 
formula: 1.38 g 5,5-diethylbarbituric acid, 8.7 gsodium, 5,5-
diethy1barbiturate and 0.39 g calcium lactate in 1 liter of distilled 
water. 
2. Agar Buffer 
The agar buffer was made according to the following formula: 
1.66 g of 5,5-diethylbarbituric acid, 10.51 g sodium 5,5-diethy1-
barbiturate and 1.54 g calcium lactate in 1 liter of distilled water. 
c. Preparation ~~. Buffer 
Agar was ob.tained from two sources (Difco Laboratories and Bausch-
& Lomb). Agarose (Bausch & Lomb, Rochester, New York) is a low~ion 
agar that has the agaropectin moiety 1)f agar removed and needed no 
further purification. Bacto Noble Agar (Difco Laboratories, Detroit, 
Michigan) was purified by the-following process: The agar was allowed 
to swell overnight in a large volume of distilled water, followed by 
a thorough washing in distilled water by means of repeated decantation 
of the supernatant from the settled agar and replacement of distilled 
water until a clear supernatant was obt-ained. When the 'supernatant 
was colorless the distilled water was decanted and the agar dehydrated 
with alcohol. The agar was then rinsed with acetone, taken ,to dryness 
on a Buchner funnel apd allowed to come to complete dryness at room 
temperature. 
To prepare the buffered agar medium, purified agar was made 2% 
(w/v) in water and the solution slowly brought to a boil. Bacterial 
growth was inhibited by the addition of sodium azide to a final 
concentration of 0.1% (w/v). The agar solution was allowed to 
solidify in 50 ml aliquots. On the day of use, this material was 
remelted in a boiling water bath and then cooled to 560 C. A 50ml 
aliquot of diethylbarbituric buffer heated to 560 C was added to the 
hot agar solution and thoroughly mixed. 
D. Procedure 
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The microtechnique of immunoelectrophoresis (Scheidegger, 1955) 
as modified by Hirsch~ld (1960) carried out on LKB Immunophor~ 
equipment (LKB Instruments, Inc., Washington, D.C.) was used for 
characterization of the serum proteins. Twenty m1 of melted agar-
buffer was applied to a horizontal frame c~ntaining six microscope 
slides previously cleaned with alcohol and coated with agar by 
immersion in a boiling solution of 0.2% (w/v) purified agar. The 
agar-buffer was allowed to solidify. Just prior to use, the slides 
were punched with a die which cut antigen wells and antibody trenches 
in to the agar. 
The slide frames were mounted on the electrophoresis cell and 
connected to the buffer in the electrode vessels with rayon wicks 
soaked in the tank buffer •. The lid was placed on the electrophoresis 
cell and 35 ma constant current, was applied for 15 minutes. The cell 
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was opened and the agar from the antigen wells was aspirated. Five to 
ten microliters (}.It 1) of serum or urine was pipet ted into the antigen 
wells. The·same current was again applied for approximately one hour, 
or until the albumin fraction of normal human serum, labelled with 
bromphenol blue, migrated 2.5 cm. 
At the discontinuance of the electrophoretic separation, the 
agar was removed from the antibody trenches and 0.1 ml of antisera 
was added. After application of the antisera, the slides were placed 
in a moist diffusion chamber and incubated at room temperature for 
approximately 24 hours. The slides were cleared of nonprecipitated 
protein and buffer salts by washing in three 24 hour rinses of 1% 
saline, followed by a 24 hour rinse in distilled water. The slides 
were dried in a hot-air dryer and then placed in the staining 
solution for 15 minutes. Excess stain was removed by several brief 
rinses in cold tap water. The final differentiation was carried out 
in 5% aqueous acetic acid. The stained slides were dried, labelled 
and photographed. 
V IMMUNOGLOBULIN QUANTITATION 
The immunoglobulins (IgG, IgA and IgM) were quantitated by radial 
immunodiffusion, using bu~fered agar gel plates impregnated with a 
specific immunoglobulin antisera (Hyland Laboratories, Los Angeles, 
California). The immunodiffusion was carried out in rectangular 
disposable polystyrene plates with snap-on lids. These plates 
contained 4 ml of agar and had six wells of equal size (1-2 mm. in 
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diameter) cut equidistant in a horizontal pattern across the agar. 
Twenty lambda of antigen (reference standard, urinary concentrate or 
serum) was pipetted into each of the wells. The IgA and IgM antibody 
containing plates were then incubated in a moist chamber at room 
temperature for 16 hours. The IgG plate was incubated for 4 hours at 
37oC. 
At the termination of the immunodiffusion, the radius of the 
precipitation around the well was measured under a calibrated 
magnifying glass. A standard curve was constructed for each of the 
immunoglobulin classes from the radii of the reference samples. The 
radius of the immunodiffusion has been found to be directly 
proportional to the concentration of the antigen. The unknown 
samples were quantitated by interpolation of the calibration curve. 
VI PROTEIN QUANTITATION 
An estimation of the serum and urinary proteins was made 
colorimetrically by the biuret method (Campbell ~~., 1963). The 
biuret reagent was made by dissolving each of the following reagents 
in about 500 mI. distilled water: 3.0 g CuS04·5H20, 12.0 g 
KNaC4H406·4H20 and 60.0 g NaOH. The sodium potassium tartrate 
solution was added to the sodium hydroxide solution and mixed. The 
cupric sulfate solution was then slowly added to this mixture and 
the final volume was brought to 2 liters. 
Analysis was made according to the following procedure: 0.2 ml 
of sample, blank and standard was added to 2.8 ml of 0.85% NaCl and 
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mixed on the Vortex Mixer® (Clay-Adams, Inc., New York). Biuret 
reagent (3.0 ml) was then added to each tube and immediately mixed. 
Protein standards, calibrated by Kjeldahl analysis, were obtained from 
Armour.Co., Chicago and from Hyland Laboratories, Los Angeles, 
California. All tubes were incubated at room temperature for 30 
minutes and read at a wave length of 520 millimicrons (mll) on a 
spectrophotometer. The protein content was calculated from a standard 
curve. 
VII DETECTION OF BENCE JONES PROTEINURIA 
A. No.n-Specific Proteinuria Screening Tests 
Two routine protein screening methods were used to detect the 
presp.nce of albumin, globulin, Bence Jones protein orproteoses. 
1. Paper Strip Indicator ~ 
Fresh urine samples were tested with a citrate buffered (pH 3.5) 
tetrabromphenolsulfonphthalein impregnated filter paper strip 
(Combistix, Ames Co., Elkhart, Indiana). An indication of protein 
content was obtained by comparison with the color scale provided with 
the indicator strips. 
2. Sulfosalicylic ~~ (magnus-Levy, 1936) 
Protein was detected by the following procedure: Four drops of 
20% (w/v) sulfosalicylic acid was added to approximately 2 ml of 
centrifuged urine and mixed. If no precipitation occurred, an excess 
of sulfosalicylic acid was then added to ensure protein detection in 
alkaline urines. Proteinuria was indicated by the presence of a 
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precipitate in the acidified urine. 
B. Specific Tests For Bence Jones Proteinuria 
Bence Jones protein testing was accomplished by an acid 
precipitation with p-to1uene sulfonic acid (Cohen!~na .R~~uchaJ~196a) 
heat and acetic acid test (Sankuh1er, 1952; Putnam, ~al., 1959) and 
a protein-paper-extraction test (Naumann, 1965). 
1. p-To1uene Sulfonic Acid (TSA) Test 
The following procedure was used: 1.0 m1. of 12% TSA (w/v) in 
glacial acetic acid was mixed with 2.0 m1. of centrifuged urine. The 
presence of Bence Jones protein was indicated by the formation of a 
precipitate after 5 minutes. 
2. ~ And Acetic !£.!!! ~ 
The following technique was used: About 10.0 m1 of centrifuged 
urine was adjusted to a pH of 4.9 with a dilute acetic acid solution 
and heated in a water bath. The temperature reading was observed on 
a thermometer in the tube of urine. The urine was brought to a 
boiling point and boiled for at least 5 minutes. While still near 
the boiling point, the urine was filtered and the filtrate was 
observed for precipitation upon cooling. Clouding of the filtrate at 
85 to 650 C was read as a positive test. 
3. Protein-Paper-Extraction Test 
This procedure was developed to differentiate urog1obu1ins and 
proteoses from Bence Jones proteinuria. The test was performed as 
follows: The uroproteins were precipitated by adding 1.0 ml of 50% 
(w/v) trichloracetic acid to 10.0 m1. of centrifuged urine. After 
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precipitation, the solution was centrifuged and the supernatant was 
decanted. One to two drops of 27% ammonium hydroxide was added to the 
precipitate. The latter was mixed and pulverized with a glass 
stirring rod~ Approximately 0.1 m1. of this suspension was absorbed 
onto a 1/8 sector of 9 cm circular filter paper (Whatman No.1). The 
paper was dried and the Benc.e Jones protein eluted in 1.5 m1. boiling 
sodium ch1ori~~acetate buffer, pH 4.3. The buffer was composed of 
100 m1. 10% NaC1, 14.0 m1. 2 M sodium acetate, 36.0 m1. 2 M acetic 
acid and distilled water to make a final volume of 2 liters. The 
buffer solution was allowed to cool for 10 minutes, then the tube was 
immersed in cooled water, the filter paper removed from the tube and 
3 drops of 20% (wI v) sulfosalicylic acid was added. The presence of 
Bence-Jones protein was indicated by a clouding of the buffer solution. 
VIII BENCE JONES PROTEIN CHARACTERIZA'lION 
Bence Jones proteins were classified as kappa type or lambda 
type by immunoelectrophoresis, using specific antisera (see Section 
IV) • 
EXPERIMENTAL RESULTS 
Serum and urinary proteins of twenty-six patients under 
treatment for a myelomatous disease were studied at the L.D.S. 
Hospital in Salt Lake City, Utah. These patients were selected on 
the basis of serum electrophoretic patterns, thermal solubility 
properties of the urinary proteins, and the availability of urine and 
serum samples for protein studies. Tn all cases, the presence of a 
myelomatous process was confirmed by the clinician through an 
evaluation of the clinical and pathologic manifestations of the 
patient's disease. 
The abnormal myeloma proteins found in this study were 
characterized by a considerable diversification in the quantitative 
elaboration of an M-component, the range in electrophoretic mobility, 
and the heterogeneity in the underlying molecular abnormality of 
gamma globulin. An arbitrary classification of the gammopathies was 
made in accordance with the clinical and laboratory findings listed 
in Table 4. Analyses for free serum L-chains were not performed, 
nor were macroglobulinemia, H-chain disease and L-chain disease 
included in this study. Of the twenty-six gammopathies studied (see 
Table 6), five were normoproteinemi~ myelomas, four Gamma-A para-
proteinemias, two Gamma-D paraproteinemias, and fifteen Gamma-"G 
paraproteinemias. In this paper, normoproteinemic myeloma has been 
used to refer to myelomas whet;'ein a study of .the urinary proteins 
was essential to establish the presence of an M-protein, since no 
evidence of an abnormal protein was discernible in the serum 
TABLE 6 
ELECTROPHORETIC FRACTIONATIONS OF SERUM PROTEINS 
Protein Concentrations (gm/IOO ml) 
Myeloma Type and Total 
Patient Designation Protein Albumin a-I Globulin a-2 Globulin B-Globulin :V-Globulin 
Normal (Mean ± 1 S. D.) 
7.1 + 0.30 5.03 ± 0.32 0.18 + 0.08 0.46 + 0.09 0.52 ± 0.12 0.92 ± 0.11 
Normoproteinemic 
Patient A 6.3 3.23 0.30 0.71 1.05 1.01 
Patient B 6.7 4.10 0.43 0~92 0.70 0.54 
Patient C 6.7 4.54 0.21 0.55 0.72 0.68 
Patient D 6.3 3.62 0.33 0.87 0.54 0.94 
Patient E 4.9 2.50 0.39 0.74 0.57 0.70 
Gannna-A 
Patient F 9.7 3.60 0.30 0.96 0.67 4.18 
Patient G 7.7 2.35 0.52 1.41 2.69 0.73 
Patient H 9.6 3.38 0.39 0.90 4.53 0.40 
Patient I 9.4 3.30 0.42 0.35 4.85 0.40 
Gamma-D 
Patient J 6.1 3.80 0.18 0.57 0.84 0.71 
Patient K 5.7 2ee53 0.23 0.74 0.60 1.61 
TABLE 6--Continued 
ELECTROPHORETIC FRACTIONATIONS OF SERUM PROTEINS 
Protein Concentrations (gm/100 m1) 
Myeloma Type and Total 
Patient Designation Protein Albumin a-I Globulin a-2 Globulin B-G1obu1in Y-G1obu1in 
GalDPla-G 
Patient L 10.8 2.89 0.35 0.81 0.89 5.85 
Patient M 7.1 4.60 0.21 0.84 0.39 1.06 
Patient N 12.0 3.87 0.36 0.43 0.74 6.50 
Patient 0 14.2 6.01 0.17 0.83 1.00 6.18 
Patient P 9.2 3.08 0.13 0.68 0.78 4.53 
Patient Q 8.5 3.91 0.28 0.61 0.67 3.02 
Patient R 9.0 3.24 0.50 0.84 0.84 3.58 
Patient: S 6.3 2.93 0.46 0.77 0.66 1.48 
Patient T 8.1 2.88 0.39 0.83 1.26 2.74 
Patient U 10.6 2.92 0.46 0.96 1.43 4.82 
Patient V 7.8 1.44 0.23 1.10 1.49 3.54 
Patient W 10.6 3.26 0.42 0.86 0.97 5.01 
Patient X 6.7 3~45 0.35 1.24 0.83 0.83 
Patient Y 7.2 3.51 0.36 0.99 0.45 1.89 
Patient Z 14.8 4.19 0.46 0.64 0.73 8.76 
TABLE 7 
ELECTROPHORETIC FRACTIONATIONS OF CONCENTRATED URINARY PROTEINS 
Myeloma Type and 
Patient Designation 
















(gm/lOO ml) Albumin 
Percent Protein Concentration 
a_I Globulin Q-2 Globulin B-Globulin 
have not been determined) 
6.5 0.5 4.0 
13.0 7.0 .. 20 .. 0 57.0 
11.'.0 7.0 8.0 
6.0 2.0 .. 2.0 28.0* 
23.0 7.0 12.0 43.0* 
4.3 16.0 14.0 
7.5 7.0 3.0 1.5 · .. 4.,5 
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* Indicates denatured protein 
Percent Protein Concentration 
a-I Globulin a-2 Globulin B-Globulin 
5.0 0 
6.0 .:- 0 
1.0 67.0 2.5 
5.5 16.0 26.0 
7.0 38~0 29.0 
34.0 21.0 










+ The solid line used in the chart indicates the range of electrophoretic mobility of the 
given protein. A precise mobility could not be designated in as much as the peak was not 
sharp and could not be differentiated. 
electropherogram. Final classification was based on serologic 
analyses by immunoelectrophoresis. 
I TOTAL SERUM PROTEINS 
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The term "hyperproteinemia" is frequently associated with the 
myelomatous process. There is no concordant opinion as to the 
precise serum protein level to which this term is applicable. The 
only consensus seems to be that in hyperproteinemia, the total 
protein value must exceed 8.0 gm/IOO ml (Jeghers and Selesnick, 1937; 
Gutman, ~.!!.., 1941; Wuhrman and Marki, 1963; Hart, et ,al., 1965). 
However, the myelomatous process may also be characterized by normo-
proteinemic and hypoproteinemic states. The Gamma-D myelomas (Hobbs, 
et al., 1966) are primarily associated with normoproteinemia, while 
the Bence Jones myelomas (Solomon and Fahey, 1964) are usually 
associated with hypoproteinemia, ornormop~oteinemia. In the series 
of twenty-six myelomatoses presented herein, thirteen cases were 
found with serum protein values of less than 8.0 gm/IOO ml (see 
Table 6). In the normoproteinemic series one patient had a total 
protein value as low as 4.9 gm/IOO mI. The average value for the 
normoproteinemic series was 6.2 gm/IOO ml. Of the remaining 
classifications, the Gamma-A series of patients were characterized 
as possessing an average value of 9.1 gm/IOO mlj the average value 
of the Gamma-D group was 5.9 gm/IOO ml and the average for the Gamma-G 
group was 9.5 gm/IOO mI. In general, the total protein values for the 
the individual cases deviated little from the average of each myeloma 
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classification, with the exception of the Gamma-G group. The range of 
the total proteins in this group was 6.3 gm/lOO ml to 14.8 gm/lOO mI. 
Five of the patients within the Gamma-G series had total protein 
values less than 8.0 gm/lOO mI. 
II CELLULOSE ACETATE ELECTROPHORESIS 
Serum electrophoretic fractionation was used in conjunction with 
other laboratory tests as a means to detect paraproteins. Para-
proteins have been defined as proteins in the serum, urine or tissues 
produced by myeloma cells (Apitz, 1940). These proteins may be 
demonstrated electrophoretically as dense s~aining bands in the 
globulin region. Quantitation of these abnormal proteins has been 
determined by densitometric analyses. The dense protein zone seen on 
the cellulose acetate medium has been found to correspond with the 
"peak" or "spike" produced on the electropherogram (Cawley, 1966). 
These protein patterns may appear as thin, homogeneous spikes or as 
additional peaks in a globulin region where under "normal" 
circumstances only one peak is observed. Figure 10 shows three gamma 
globulin peaks in an area where there is usually only one peak. The 
presence of a paraprotein in the serum does not constitute a diagnosis 
of myeloma. Approximately 10 per cent of patients with demonstrable 
serum paraproteins do not have an associated neoplasia (Cawley, 1966). 
Benign pseudo-M-proteins must be differentiated from true gammo-
pathies by other laboratory examinations and by long-term follow-up 
I 
studies. Preclinical myeloma may be indicated by the presence of a 
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paraproteinemia in the electrophoretic pattern as early as seventeen 
years in advance of the development of clinical myeloma (Norgaard, 
1964). As previously stated, the electrophoretic detection of a 
paraprotein was confirmed as a manifestation of the myelomatous 
process before being included in this study. 
Electrophoretic separation of the proteins of the myeloma sera 
and urine was performed primarily on a cellulose acetate medium. The 
mobility of each fraction was determined and the concentration 
calculated. Table 6 and Table 7 are compilations of these data. The 
patients are grouped according to the immunoglobulin class of the 
paraprotein. Representative and unusual electrophoretic patterns 
from each of the myeloma classes studied are given in Figure 6 
through Figure 12. 
In the normoproteinemic series, no abnormal globulin was evident 
in the sera; however, in almost every instance, a pronounced protein 
component was found in the urine (see Tables 6 and 7). Immunologic 
studies of these components are described.in Section VI. Figure 6 
shows the serum and urine e1ectropherograms from a representative 
patient in this group. 
An examination of the electrophoretic patterns of the Gamma-A 
type myelomas showed that the mobility of the M-protein in the serum 
ranged from the gamma globulin region through the beta globulin 
region, with a predominance in the latter. In all but one instance 
(see Table 6) the concentration of M-protein was above 4.0 grams per 
cent. The mobility of the M-proteins in the urine also ranged 
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Electrophoretic and immunoelectrophoretic patterns of serum and urine proteins. A normal 
human serum pattern, designated "NHS", is shown at the top of the immunoelectrophoresis for 
comparison. The antisera used in the immunoelectrophoresis is indicated to the right of 
the photograph. 
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Figure 7. Electrophoretic and immunoelectrophoretic patterns of serum and urine proteins. A normal 
human serum pattern, designated "NHS", is shown at the top of the immunoelectrophoresis for 
comparison. The a~tisera used in the immunoelectrophoresis is indicated to the right of G'~ 
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the photograph. 
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Electrophoretic and immunoelectrophoretic patterns of serum and urine proteins. A normad 
human serum pattern, designated IINHSII is shown at the top of the immunoelectrophoresis for 
comparison. The antisera used in the immunoelectrophoresis is indicated to the right of 
the photograph. 


































Figure 9. Electrophoretic and immunoelectrophoretic patterns of serum and urine proteins. A normal 
human serum pattern, designated "NHS", is shown at the top of the immunoelectrophoresis for 
comparison. The antisera used in the immunoelectrophoresis is indicated to the right of ffi 
the photograph. 
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Figure 10. Electrophoretic and immunoelectrophoretic patterns of serum and urine proteins. A normal 
human serum pattern, designated "NHS", is shown at the top of the immunoelectrophoresis for 
comparison. The antisera used in the immunoelectrophoresis is indicated to the right of $ 
the photograph. 























Electrophoretic and immunoelectrophoretic patterns of the serum proteins. A normal human 
serum pattern, designated "NHS", is shown at the top of the immunoelectrophoresis for b 
comparison. The antisera used in the immunoelectrophoresis is indicated to the right of 
the photograph. 
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Figure 12. Electrophoretic and immunoelectrophoretic patterns of serum and urine proteins. A normal 
human serum pattern, designated "NHS", is shown at the top of the immunoelectrophoresis forj::::l 
comparison. The antisera used in the immunoelectrophoresis is indicated to the right of 
the photograph. 
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between the gamma and beta globulin regions (see Table 7). The 
mobility of the M-protein in the urines did not necessarily correlate 
with the mobility of the M-protein in the sera. Representative 
examples of the electrophoretic patterns obtained in the Gamma-A 
myelomas are given in Figure 7 and Figure S. 
In this myeloma series there were two Gamma-D myelomas. No 
detectable abnormal .protein band was evident in the serum or urine of 
the one case, patient J, while in the other case, Patient K, a very 
diffuse band was demonstrated in the Gamma-l region of the serum 
electropherogram. An abnormal protein peak comprising 90% of the 
total protein was also seen in the Gamma-l position in the urine 
electropherogram (see Figure 9). 
Electrophoretically, the Gamma-G myelomatoses constituted a very 
heterogeneous population in terms of the mobility range of theM-
component, the quantity of this component in the serum and urine, and 
the number of molecular abnormalities expressed in the electrophoretic 
pattern as additional peaks. Because of the marked heterogeneity in 
the electrophoretic patterns of the Gamma-G myelomatoses, three cases 
were selected to demonstrate some of these abnormalities (see Figures 
10, 11, and 12). The electropherogram of patient M (see Figure 10) 
shows three peaks in a region where only' one peak is "normally" seen 
in the serum. A single gamma spike was observed in the urine. 
Patient S (see Figure 11) had a normal total protein concentration. 
The electrophoretic fractionation of the serum proteins was quantita-
tively normal, with the exception of a reduction of the albumin 
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fraction. While the globulin fractions were present in normal 
concentrations, an abnormal spike appeared in the gamma region with 
an apparent reduction of normal gamma globulin. A urine specimen was 
not obtained from this patient. The serum and urine electrophoretic 
patterns of patient Z (see Figure 12) represent protein patterns that 
are frequently associated with so-called "classical" Gamma-G myeloma. 
The broken line in the gamma globulin fraction indicates that the 
elevation of the M-component was so marked that the pattern would 
have exceeded the margins of this chart. 
Attempts have been made to distinguish Gamma-A and Gamma-G 
myelomas according to the differences in the size of the base of the 
M-protein in the electrophoretic pattern. Laurell and Heremans (1961) 
have proposed that statistically Gamma-A type myelomas are found to 
have broader bases than Gamma-G type myelomas. In the present study, 
this finding was supported in all of the Gamma-A myelomas and in all 
but two cases of Gamma-G myelomas. In one of the Gamma-G cases, 
patient P, the paraprotein was associated with a cryoglobulin. In 
the other case, patient U, the paraprotein appearedelectrophoretically 
as a grossly serrated band in the gamma globulin region on cellulose 
acetate medium. A serrated band is sometimes produced on cellulose 
acetate strips when there is a very homogeneous protein in excess. 
In spite of these findings, this criterion for differentiating 
myeloma types may not be reliable. First,since the observations of 
Laurell and Heremans (1961), another myeloma type, Gamma-D, has been 
reported. Of the two Gamma-D myelomas presented in this report, one 
74 
of these cases, patient K, was found to have a diffuse, broad based 
band (see Figure 9), similar to the Gamma-A type myelomas. A second 
reason for criticizing the approach of Laure11 and Heremans in the 
prediction of myeloma types is that hypergammag1obu1inemias, 
characterized by a diffuse broad banding of the fmmunog1obu1ins on 
paper or cellulose acetate electrophoresis, may appear in conditions 
not associated with Gamma-A globulin and not associated with myeloma, 
such as chronic infection, which is usually associated with elevated 
levels of Gamma-G globulin or hepatic parenchymal disease, which is 
frequently associated with Gamma-M globulins (Alper ~~., 1966). 
III DETECTION OF BENCE JONES PROTEINURIA 
With the detection of proteinuria, classification of the anomaly 
may be relegated into two broad groups: protein disturbances 
resulting from renal involvement, or protein disturbances of the 
myelomatous process with an associated Bence Jones proteinuria 
(Naumann, 1965). Of the many tests that have been devised for the 
detection of proteinuria, some are too insensitive and others are too 
nonspecific to be of diagnostic value. Only one or two may be used 
to differentiate the proteins in the urine. 
The indicator test using filter paper strips impregnated with 
citrate buffered (pH 3.5) tetrabrompheno1su1fonphtha1ein frequently 
gives false negative reactions in the presence of significant Bence 
Jones proteinuria due to the pH dependency in the dye reaction 
(Smith, 1963). The sulfosalicylic acid procedure, a nonspecific 
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protein test, has been reported to give reactions in the presence of 
significant amounts of Benc.e Jones protein, urog1obu1ins, or albumins 
(Alper..!! a1., 1966; Naumann, 1965; Smith, 1963). The p-to1uene 
sulfonic acid (TSA) and the heat and acetic acid tests are methods 
described for the detection of Bence Jones proteinuria. However, it 
has not always been possible using these tests to distinguish Bence 
Jones protein from urog1obu1ins. A protein-paper-extraction test has 
been devised (Naumann, 1965) which has been reported to be more 
specific than the two previously mentioned tests and enables 
diffe~entiation of Bence Jones proteins from the uroproteins. 
Initial screening tests for Bence Jones proteinuria in this study 
included the sulfosalicylic acid tests and the CombistixaD test. 
Specific testing was performed with p-to1uene sulfonic acid, the 
heat and acetic acid and the protein-paper-extraction methods. The 
results of these examinations are given in Table 8. 
IV CALCIUM 'LEVELS AND RADIOLOGIC SURVEYS 
Hypercalcemia is purported to be a symptom commonly associated 
with the widespread skeletal lesions and degenerative ~hanges that 
occur in the myelomatous process (Osserman, 1965; Brodsky, .lla1., 
1967). Hypercalcemia of multiple myeloma may presumably result from 
an increase in diffusible calcium due to bone demineralization. 
Additionally, it is possible that elevated serum calcium levels could 
be initiated by hyperproteinemia (Rawson and Sunderman, 1948). There 
are several factors involved in the hyperproteinemia of myeloma that 
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TABLE 8 - Continued 
DETECTION OF PROTEINURIA 
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could account for hypercalcemia. Only nonprotein bound calcium is 
filtered at the glomerulus (Goldman, 1962) and increased calcium-
binding properties of the serum proteins have been reported in 
myelomatous conditions (Rawson and Sunderman, 1948). However, 
hyperproteinemia may not be the mechanism involved since there is 
frequently no correlation between the tot~lserum calcium and the 
total serum proteins ~n this disease (Gutman~Al., 1936; Apo~te, 
1963). The data presented herein suggested that hypercalcemia was 
not necessarily a concurrent finding with osteolysis and bone 
destruction. The calcium levels and the results of the radiologic 
surveys, i.e., the presence of osteolysis or pathologic fractures, 
are shown in Table 9. Of interest is that at the time of diagnosis 
only three cases exceeded the normal range for the serum calcium 
concentrations, and with subsequentte$ting only five cases were 
found to have inc+eased calcium levels; extensive bony involvement 
was a usual finding in the myelomatoses studied. 
V HEMATOLOGIC FINDINGS 
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Table 10 lists the hematologic findings at the time of diagnosis 
of the myelomatoses. In general, these data were consistent with 
other values reported for the myelomatous conditions. The percentage 
of plasma cells in the bone marrow ranged fr~ 6% to 80%. In several 
instances, the plasma cells were not enumerated since the aspirate 
consisted almost entirely of plasma cells. The low plasma cell 
percentages reported in other cases may Dot be representative of the 
TABLE 9 
SERUM CALCIUM LEVEL AND BONE DEGENERATION 
Myeloma Type and Bony Involvement As Evidenced By Radiologic Survey 
Patient Designation Patieq.t Age Serum Calcium mg% Osteoporosis Pathologic Frac~ures 
Normoproteinemic 
Patient A 70 9.8 + + 
Patient B 10.4 + 
Patient C 63 . 10.3 + 
Patient D 48 10.3 
Patient E 74 15.6 ± 
Gamma-A 
Patient F 55 10;2 + + 
Patient G 78 10.2 + + 
Patient H 66 8.2 
Patient I 70 12.8 
GaDIDa-D 
Patient J 44 10.3 + 
Patient K 62 9.0 + + 
Myeloma Type and 
Patient Designation Patient Age 
Gamma-G 
Patient L 49 
Patient M 73 
Patient N 72 
Patient 0 64 
Patieut P 47 
Patient Q 63 
Pat~nt R 72 
Patient S 61 
Patient T 59 
Patient U 64 
Patient V 71 
Patient W 74 
Patient X 49 
Patient Y 32 
Patient Z 65 
TABLE 9--Continued 
Bony rbvolvement As Evidenced 


























HEMATOLOGICAL FINDINGS AT THE TIME OF DIAGNOSIS 
Myeloma Type and VPRC* WBC* Platelets ESR* Rouleaux %P1asma Cells 
Patient Designation (%) (mm3) (mm3) (mm/hr) Formation (Bone Marrow) 
Normo.pro teinem.ic 
Patient A 40 4,200 Adequate 31 
Patient B 40 5,500 106,000 15 
Patient C 45 5,750 550,000 39 Num.erous 
Patient D 24 11,600 Adequate 24 
Patient E 37 22,700 66,000 ++- 61 
Gamma-A 
Patient F 28.5 3,400 138,000 +t++ 42 
Patient G 32 7,100· Adequate 60 + 6 
Patient H 31 15,200 Decreased 80 
Patient I 27 9,000 178,000 + 34 
Gamma-D 
Patient J 44 7,400 255,000 36 13 
Patient K 27 5,200 74,000 Numerous 
TABLE lO-Continued 
HEMATOLOGICAL FINDINGS AT THE TIME OF DIAGNOSIS 
Myeloma Type and VPRC* WBC* 
Patient Designation(%) (mm3) 
Gamma-G 
Patient L 25 10,400 
Patient M 27 1,700 
Patient N 27 3,400 
Patient 0 34 8,000 
Patient P 27 6,200 
Patient Q 40 4,500 
Patient R 31 18,400 
Patient S 46 5,200 
Patient T 35 4,300 
Patient U 48.5 6,500 
Patient V 29 5,700 
Patient W 29.5 7,300 
Patient X 46 10,000 
Patient Y 45 4,200 
Patient Z 32 2,500 
* VPRC = Volume Packed Red Cells 

















































actual p~oliferation of these cells. Frequently at autopsy a massive 
plasma cell infiltration throughout the bone marrow and reticulo-
endothelial organs was found even though puncture or biopsy may not 
have shown bone marrow infiltration of plasma cells early in the 
course of the disease. 
VI IMMUNOLOGIC CHARACTERIZATION 'AND 'QUANTITATION 
The application of the principles of immunoelectrophoresis 
enables classification of the myeloma proteins into a number of 
composite globulin groups (see Table 4). These tmmunoglobulinsmay 
be found to exhibit many different molecular aberrations. For 
example, Figure 10 illustrates a serum electrophoretic pattern with 
three gamma globulin moieties, yet the abnormality falls into the 
Gamma-G group because the serum contains an increase ofa very 
homogeneous Gamma-Gglobulinwith an L-chain subunit. The moiety 
labeled as Gamma-l (Figure 10) was presumed to be normal Gamma-A and 
Gamma-M globulin in reduced concentrations. The moiety labeled 
Gamma-2 consisted of lambda-type (designated Type II in Figure 10) 
light chains unassociated with any heavy chains of gamma globulin. 
The moiety labeled as Gamma-3 consisted of Gamma-G globulin heavy 
chains associated with lambda-type light chains. The urine consisted 
predominantly of unassociated lambda-type Bence Jones proteins. In 
addition to these molecular aberrations, polymerization may occur 
(Bernier and Putnam, 1963). Light chains are frequently dimerized. 
If the paraprotein in the serum is found to consist of a homogeneous 
immunoglobulin molecule, the urine may contain only one of the 
polypeptide components, either as a monomer, dimer or polymer. 
The use of specific heavy chain antisera has allowed the 
classification of the myelomatoses into the Gamma-G, Gamma-A, or 
Gamma-D groups (see Figure 7 through Figure 12). Because of the 
considerable overlap of the mobility of the Gamma-A, Gamma-D, 
Gamma-G and Gamma-M globulins upon paper or cellulose acetate 
electrophoresis, serologic identification of the immunoglobulin is 
necessary to distinguish these .. groups. Figure 7 illustrates the 
electrophoretic patterns of the serum and urinary proteins from a 
Gamma-A myeloma. The serum abnormality is in the beta region while 
the urine abnormality is in the gamma region. Since both Gamma-G 
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and Gamma-A paraproteins may occupy these electrophoretic regions, 
without serologic identification, classification would be impossible. 
Immunoelectrophoresis characterized both of these proteins as Gamma-A 
globulins. 
The urine of normoproteinemic myelomas usually contain an 
abnormal protein which does not consist of any of the common gamma 
immunoglobulin heavy chains (lgG, IgA, IgM, or IgD). Figure 6 gives 
an example of this nonreactivity with polyvalent antisera. The urine 
appears to be devoid of any of the ~unog1obu1in components, yet 
strong reactivity is obtained with specific light chain antisera. 
A classification of each of the myeloma groups was made on the 
basis of reactivity with 1:ype specific light chain antisera. Each of 
the immunoglobulin groups in normal human sera contain both kappa and 
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lambda type light chains with an approximate frequency of 2:1 
respectively (Mannik and Kunkel, 1963b). The myeloma proteins contain 
only one type of light chain polypeptide •. In most instances, the 
light chain antigenic typing of the myeloma protein in the seru~ 
corresponds to the Bence Jones protein excreted in the urine (Mannik 
and Kunkel, 1962). In this series the serum or urinary proteins of 
ten patients reacted with kappa light chain antisera and the serum or 
urinary proteins of an additional ten patients reacted with lambda 
light chain antisera. Table 11 lists the kappa and lambda light 
chain typing and immunoglobulin quantitation of the Gamma-A, Gamma-G, 
and Gamma-M proteins of the patients in tqis series. 
Of particular interest in this study was the observation that 
when the IgA and IgD myeloma proteins were found to consist of 
lambda··type light chains there was a concommitanf reduction of IgG 
immunoglobulin concentration (see Table 11). Conversely, when the 
light polypeptide chains of the IgAand IgD myeloma proteins reacted 
with kappa type light chain antisera Gamma-G levels were quantitatively 
normal. 
TABLE 11 
LIGHT CHAIN DESIGNATION AND IMMUNOGLOBULIN CONCENTRATION 
IMMUNOGLOBULIN QUANTI TAT ION (mg/IOO ml) 
Myeloma Type and Specific G Serum Level Urine Level 
Patient Designation Light Chain Ig$ IgA IgM IgG IgA 
Normal Range <.± 1 S.D.) 1020-1460 300-480 85-155 Unknown Unknown 
Normoproteinemic 
Patient A Kappa 
Patient B Kappa 320 95 20 120 0 
Patient C 
Patient D 650 40 25 210 20 
Patient E Lambda 1050 50 40 300 30 
Gamma.-A 
Patient F Kappa 1050 4000 30 100 40 
Patient G Kappa 1200 620 30 270 300 
Patient H Lambda 205 490 15 10 225 
Patient I Lambda 350 2100 0 
Gamma-D 
Patient J Kappa 1250 70 15 































LIGHT CHAIN DESIGNATION AND IMMUNOGLOBULIN CONCENTRATION 
IMMUNOGLOBULIN QUANTI TAT I ON :(mg/10Q m1) 
Specific Serum Level Urine Level 
Light Chain IgG. IgA IgM IgG IgA 
Kappa 2040 40 30 1500 0 
Lambda 1500 45 20 125 0 
Kappa 2630 35 15 600 0 
Lambda 950 45 20 400 0 
Kappa 1350 45 35 175 0 
Kappa 1910 50 50 290 25 
Lambda 2060 35 10 840 0 
------ 1920 55 30 




4400 950 20 0 40 
Lambda 215 0 
------ 1850 50 30 25 0 

















Immunologic and physiochemical procedures have been employed in 
the study of twenty-six selected cases of multiple myeloma. These 
plasmacytic dyscrasia:? include examples of M· -protein elaboration of 
the Gamma-A, Gamma-D, and Gamma-G immunoglobulins or their polypeptide 
subunits. The majority of these cases had a single abnormal component 
in the serum. In the instances where. a paraprotein was present in 
the urine, this component appeared to be of the same light chain type 
of immunoglobulin class as the serum component. Also included in 
this study were examples of the Bence Jones or normoproteinemic 
myelomas. An apparent disorder in normoproteinemic myelomas is not 
readily discernible in the serum, but myelomatous disease becomes 
evident from the proliferation of plasma cells, skeletal degeneration 
and the frequent occurrence of an electrophoretically homogeneous 
urinary protein. 
The results of detailed analyses of the serum and urinary protein 
characteristics and other relevant laboratory findings of each of the 
twenty-six myeloma cases studied has been presented in tabular form. 
Table 6 through Table 11 should be consulted for the specific 
laboratory data of any single case. Only representative electro-
phoretic and immunoelectrophoretic patterns from each of the gammo-
pathiesstudied has been presented in Figure 6 through Figure 12. 
The Gamma-G and normoproteinemic myelomas are of particular 
interest from the standpoint of molecular heterogeneity. The 
proteins from these groups represent a large heterogeneous population 
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of antibodies with different specificities. The Gamma-A myelomas 
appear to be the most homogeneous group by a variety of criteria 
(Franklin and Lowenstein, 1964). The Gamma-D myelomas will in all 
probability, also, be distinguished by their homogeneity, since these 
proteins have been selected out of the normoproteinemic class. 
Doubtlessly, the normoproteinemic group will yield other new 
classes of immunoglobulins, but description must await proliferative 
changes resulting in a copious production of an antibody that would 
"normally" be present in trace quantities. In order to form a new 
immunoglobulin class, the antisera to the protein must be nonreactive 
with the proteins of the established immunoglobulin classes (W.H.O. 
1964; Kunkel ~ al., 1966) and should presumably react at least 
minimally with a component present in normal human sera. 
The largest and perhaps most heterogeneous class of immuno-
globulins is the Gamma-G proteins. Among other activities,the 
antibodies in this class effect the neutralization of viruses and 
bacterial toxins (Gitlin, 1966). The proteins in this class are 
related immunochemically, but also contain many distinct components 
as evidenced by the serum electrophoresis of Patient M and the 
immunoelectrophoresis of Patient Z. 
In general, hyperproteinemia was not the characteristic .finding 
in the myelomatoses studied; half of the patients in this series were 
found to be normoproteinemic or hypoproteinemic. Erythrocyte 
sedimentation rates -and rouleaux formation have been used to indicate 
the presence of these serum immunoglobulin abnormalities (Marmont, 
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~ al., 1957; Levin and Ritzmann, 1966). The expected correlation of 
elevated serum calcium levels with the occurrence of osteoporosis and 
skeletal degeneration was not evident. Bone destruction as a result 
of the myelomatous process was indicated by radiologic survey in 19 
of the twenty-six patients; whereas, hypercalcemia was present in 
only five patients. 
The chemotherapeutic agent, Melphalan, has been reported to be 
of value in the management of the myelomas, with a preferential 
response occurring in kappa type myelomas (Bergsagel, .!1.!!.., 1965). 
Light chain typing was undertaken and the clinical course of the 
disease was reviewed, however insufficient follow-up studies 
precluded any evaluation of the therapeutic response in these patients .• 
The correlation of iImnunocyte (plasma cells and lymphocytes) 
proliferation with immunoglobulin ,production has been described by 
Bjoerneboe and Gormsen ,(1943), Fagraeus (1948), and Campbell and Good 
(1949). Of the cases studied herein the probable source of the 
abnormal human immunoglobulins in multiple myeloma was the plasma 
cell. Marked plasma cell proliferation was evident from bone marrow 
aspirate or histologic studies at autopsy. 
In general, the class specific immunoglobulin antisera used in 
this study strongly demarcated the M· 'components into each of the 
immunoglobulin classes; however, light chain differentiation was not 
so pronounced.. The reliability of immunologic typing with antisera 
is questionable because of the procedure involved in the preparation 
of this material. This is 'particularly evident in the preparation of 
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ltght chain antisera. The most apparent inconsistency is introduced 
by the antigen used to elicit antibody response. The most available 
sources of antigen are the pathologic proteins produced in myelomatous 
conditions. Amino acid sequence analyses of these proteins have 
reuealed that for each individual case of multiple myeloma a distinct 
kappa or lambda chain is produced; therefore, the antisera from a 
single paraprotein would not be expected to react with all other 
proteins within that specific light chain type. 
Amino acid residue studies have shown that the peptide sequences 
of t.he C· -terminal half of light chains are identi,cal, whereas the 
N-terminal half of the pap tide has considerable variation (Hilschmann 
and Craig, 1965; Titani_~_;.!!. ... , 1965). It is a likely supposition 
that the kappa and lambda antigenic determinants may be present on 
the common portion of the light chain, while the unique reactivity of 
the light chain in myelomatoses may be accounted for in the variable 
portion of the polypeptide (Fleischman, 1966). 
An additional inherent difficulty in the preparation of light 
chain antisera is the presence of extraneous protein material in the 
antigenic source. Since concentrated urine proteins are frequently 
used as the antigenic source, proteins other than the immunoglobulins 
are present. Other proteins present in trace amounts are principally 
albumin, transferrin and urine mucoids. 
Type specific reactivity of light chain antisera requires 
purification of the antisera. The purification method introduces 
several other inconsistencies." Type specificity is produced by 
92 
absorption of the antisera with theheterologoua,light chain type. 
The antigen used for this absorption is also obtained from pathologic 
material and has the same margin for ,error as was previously discussed. 
A second inconsistency is introduced by the dissociation of the 
antigen-antibody complex during the absorption process. The 75 
antigen complexes are soluble in antigen excess, therefore, incomplete 
absorption of the heterologous light chain antibody may be obtained. 
QU4ntitative measurements of the normal immunoglobulins in 
plasmacytic malignancies indicate that there is a reduction in the 
synthesis of these proteins (Barth ~ .!!.. , 1964; Solomon.!! al., 
1963b). It ,has been reported that in multiple myeloma the abnormal 
immunoglobulin is greatly increased, while all other gamma globulin 
components are markedly reduced (Fahey and Lawrence, 1963). It was 
observed in this study that there was a direct correlation .between 
the specific light chain type of the Gamma-A and Gamma-D myeloma 
proteins and the quantity of the Gamma-G protein elaborated. Kappa 
type Gamma-A and Gamma-D myelomas were associated with normal levels 
of Gamma-G, while lambda type Gamma-A and Gamma-D myelomas were 
associated with a reduced level of Gamma-G protein. This.relationship 
was not evident in the no~oproteinemic myelomas. The Gamma-Glevels 
of the Gamma-A and Gamma-D myelomas reported here are not consistent 
with the reduced immunoglobulin levels referred to above. A 
confirmation of these findings would necessitate the study of larger 
nUlllbers of these two gammopathies. 
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It has been suggested that with the occurren~ of fmmunocyte 
differentiation an individual cell is confined to the production 
of one type of class specific polypeptide (a, 0,; y or lJ) and one 
type of light polypeptide (K or A) (Curtain ~ al.,1959; van 
Furth, 1964; Bernier and Cebra, 1965). With rare exception, more 
than one type of heavy chain does not appear within the same cell, 
nor are both kappa and lambda polypeptide chains found coexisting 
within the single cell. However, most individual cells contain 
both of these molecular species, i.e., one class of heavy 
polypeptide and one type of light polypeptide. Some cells have 
been found to·contain only one molecular species, either one type 
of light chain or one class of heavy chain, with the concomitant 
absence of the other constitutive polypeptide of the antibody 
molecule (Bernier and Cebra, 1965). Therefore, it would be 
expected that cells exist which are exclusive producers of a 
single molecular species. 
Since lambda type polypeptides are produced with less frequency 
than the kappa type proteins it is plausible that the limiting 
factor in lambda type myeloma could be the availability of these 
polypeptides. This concept would be particularly feasible in the 
Gamma-A and the Gamma-Dmyelomas, because the Gamma-A and Gamma-D 
proteins "normally" represent only a small portion of the total serum 
immunoglobulin level (21% and 0.2%, respectively, Fahey, 1965). In 
neoplastic states thesetmmunoglobulins must have a high rate of 
synthesis in order to account for the serum levels obtained, 
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especially if their catabolic rates are increased in hypergamma-
globulinemic states, as are the catabolic rates of Gamma~G in 
conditions of e~cessive production. Apparently it is possible for 
the catabolic rates of Gamma-G globulin to double or triple if 
serum protein levels are greatly increased (Fahey and Robinson, 
1963). 
A number of mechanisms could exist to account for the reduction 
of Gamma-G components in the lambda type myelomas on the basis 
of cellular synthesis or the utilization of catabolic products. 
If immunocyte differentiation did not occur or if mature 
immunocytes were found to p~oduce more than one distinct 
immunoglobulin, an explanation would be apparent. However, if 
lambda type light chains were the limiting factor in Gamma-G 
production, it would be anticipated that in Gamma-A and Gamma-D 
myelomas assays for free serum lambda chains should be negative. 
The assays of Williams ~ al., (1966) do not confirm this 
hypothesis. It is suggested that another approach to this problem 
might be through tbe use of immunofluorescent localization studies 
of the immunoglobulins in the plasma cells of the bone marrow. It 
is possible that this procedure would ascertain whether or not 
plasma cell differentiation actually occurs in the malignant states. 
SUMMARY 
1. Serum and urinary proteins from 26 patients with myeloma were 
analyzed serologically and electrophoretically. On the basis of 
such analyses the 26 cases were classed serologi~ally as Gamma-A, 
Gamma-D, Gamma-G and normoproteinemic. 
2. Hematological, radiological, and other clinical findings 
associated with the myelomatous disease, or otherwise applicable , 
to interpretative analyses of serological data, were reviewed. 
3. In general, hyperproteinemia was not the usual finding in the 
gammopathies studied. Total serum protein values of less than 
8.0 gm/100 ml occurred in the sera of 13 cases in this series. 
4. Considerable diversification was present in the electrophoretic, 
patterns of the serum and urinary proteins. The evidence of an 
abnormal component ranged from negligible to the appearance of 
three distinct peaks in an electrophoretic region where only one 
peak "normally" occurs. Quantitative estimation of an M component 
in the sera ranged from negligible to 8.8 gm/lOO mI. 
S. Proteinuria was detected by the sulfosalicylic acid test, the 
Combistix(R) test, the p-toluene sulfonic acid test, the heat 
and acetic acid test, and the protein-paper-extraction test. 
The presence of proteinuria was demonstrated in the urine of 
18 of the 23 patients tested. 
6. Hypercalcemia was not a common finding in this study, while 
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extensive: _pony involvement was a usual finding. Evidence of 
lytic skeletal destruction was found in 19 patients; associated 
hypercalcemia was apparent iIi only 2 of these patients. 
7. Hematologic findings did not differ appreciably from other 
values reported for the myelomatoses-. 
8. Proteins of 20 patients were typed with light chain antisera. 
Of these, 50% were found to be kappa type light chains and 50% 
were lambda type light chains. In this series Gazmna-A and 
Gamma-D myeloma proteins consisting of lambda type light chains 
were associated with a reduced serum level of IgG immuno-
globulin, whereas Gamma-A and Gamma-D proteins consisting of 
kappa type light chains were associated with quantitatively 
normal serum IgG levels. 
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